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A B S T R A C T
Recent developments in imaging technologies now allow the documentation, qualitative and quantitative eva-
luation of peripheral retinal lesions. As wide field retinal imaging, capturing both the central and peripheral
retina up to 200° eccentricity, is becoming readily available the question is: what is it that we gain by imaging
the periphery? Based on accumulating evidence it is clear that findings in the periphery do not always associate
to those observed in the posterior pole. However, the newly acquired information may provide useful clues to
previously unrecognised disease features and may facilitate more accurate disease prognostication. In this re-
view, we explore the anatomy and physiology of the peripheral retina, focusing on how it differs from the
posterior pole, recount the history of peripheral retinal imaging, describe various peripheral retinal lesions and
evaluate the overall relevance of peripheral retinal findings to different diseases.
1. Introduction
Since the invention of the first ophthalmoscope in 1851 by Hermann
von Helmholtz, imaging the retina has undergone dramatic improve-
ments, not only arousing interest in previously undescribed abnormal-
ities but changing our understanding of numerous retinal and choroidal
diseases (Keeler, 2002). The continuous advances in imaging technol-
ogies enabled the capture of retinal areas beyond the posterior pole,
which were not previously routinely documented digitally. The in-
troduction of ultra-widefield imaging (UWFI) led to a renewed interest
in lesions in the peripheral retina and a better understanding of their
relevance to the diagnosis and prognosis of different retinal conditions.
To develop appropriate understanding of the images generated by novel
technologies, several principles need to be considered. An under-
standing of the anatomy of the entire neurosensory retina and choroid/
retinal pigment epithelium (RPE) interface and the differences and si-
milarities between the different geographic retinal locations must be
developed. These can help to establish appropriate descriptive ter-
minologies to describe and interpret the different UWFI modalities such
as colour imaging, fundus auto fluorescence (FAF), fundus fluorescein
angiography (FFA) and indocyanine green (ICG) angiography.
2. The structure and function of the peripheral retina
2.1. Definition of the peripheral retina
Based on ophthalmoscopic examination a readily recognizable fea-
ture of the neurosensory retina is the optic disc, the exit point for the
ganglion cell nerve fibres and central veins, and entry point for arteries
supplying the inner layers of the neurosensory retina. The arteries form
the so called “arcade” encompassing the macula, including the foveola
(Yamada, 1969), fovea, parafovea and perifovea, definitions that are
essential for image analysis of fundus photographs and define the
widening areas around the foveola (Bringmann et al., 2018; Provis
et al., 2005). The fovea containing the foveola is the place of the highest
visual acuity (Hirsch and Curcio, 1989). Other landmarks of the macula
are the foveal avascular zone and the visually recognizable yellow
macular pigment.
https://doi.org/10.1016/j.preteyeres.2018.10.001
Received 24 June 2018; Received in revised form 1 October 2018; Accepted 7 October 2018
∗ Corresponding author. The Wellcome-Wolfson Institute for Experimental Medicine School of Medicine, Dentistry and Biomedical Science, Queen's University
Belfast, 97 Lisburn Road, Belfast, BT9 7BL, United Kingdom.
1 Percentage of work contributed by each author in the production of the manuscript is as follows: Nicola Quinn 25%; Lajos Csincsik: 20%; Erin Flynn 5%; Christine
Curcio10%; Szilard Kiss 5%; SriniVas R. Sadda 5%; Ruth Hogg 5% ; Tunde Peto10%; Imre Lengyel 15%.
E-mail address: i.lengyel@qub.ac.uk (I. Lengyel).
Progress in Retinal and Eye Research xxx (xxxx) xxx–xxx
1350-9462/ © 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
Please cite this article as: Quinn, N., Progress in Retinal and Eye Research, https://doi.org/10.1016/j.preteyeres.2018.10.001
Retinal regions based on gross anatomy including vessels was de-
fined in 1961 by Duke-Elder who categorised the peripheral retina into
four zones (Duke-Elder, 1961). These zones are: 1) the near periphery, a
1.5 mm ring adjacent to the 6mm diameter macula (centred on the
foveola and often defined as the posterior fundus); 2) the middle per-
iphery, the next 1.5mm ring; 3) the far-periphery, measuring the next
9–10mm on the temporal and 16mm on the nasal side; 4) the ora
serrata or extreme periphery, measuring the additional 2.1mm in the
temporal and 0.7 mm on the nasal side. In 1967 Rutnin divided the back
of the eye into 3 regions: 1) posterior fundus, a circle centred on the
foveola and including the optic disc; 2) equatorial zone, a ring shaped
area about 5.83mm wide adjacent to the posterior fundus and bordered
by an imaginary circle through the posterior extremities of the vortex
veins; 3) and the ora serrata, the area outside of the equatorial zone
(Fig. 1) (Rutnin and Schepens, 1967).
Human retinal regions based on the cellular content of the neuro-
sensory retina were defined by Polyak (1941), which we will examine
in detail in 2.3.3. For the purpose of this review, the peripheral retina
will be considered as area peripheral to the macula, a retinal region that
can itself be subdivided (see section 2.3).
Grading for retinal abnormalities in clinical studies still use different
definitions, evidenced by the use of different grading grids summarized
in Section 4. It is important to recall that grading grids, like all metrics,
were developed to investigate specific diseases, for specific purposes, by
investigators following then-current models of pathogenesis. Thus, it is
prudent to periodically ask whether these grids still make sense in the
light of new knowledge.
2.2. Embryological differences between the central and peripheral retina
The embryological development of the retina is a complex process
(Oyster, 1999; Provis, 2001; Venters et al., 2013, 2015). At birth, the
retinal neuronal cytoarchitecture and physiology is still immature and
continues to undergo changes for several years (Hildebrand and Fielder,
2011). Retinal development is known to begin centrally before ex-
tending peripherally, further expansion of the peripheral retina con-
tinues and matures before the posterior pole (Hendrickson and Drucker,
1992). The initial stage of growth involves the neural tube. As devel-
opment proceeds, optic vesicles evaginate, producing a bi-layered optic
cup with an inner and outer layer subsequently differentiating into the
sensory neural retina and the RPE, respectively (Hendrickson, 2016).
Following this initial differentiation, the most central portion of the
neural retina is thought to differentiate early with cells at the peripheral
retina margins remaining proliferative and thus differentiating last. In
fact the proliferating capacity of the peripheral retina appears to be
retained in adults, at least in animal models (Al-Hussaini et al., 2016).
Previous work by Venters et al. (2013) has provided useful insights
into the derivation of mature eye tissues by a vital labelling strategy of
chick embryos. They demonstrated that significant portions of the
peripheral retina is made up of cells that resided at the optic cup lip and
these same cells did not make up any of the central retina, providing the
first evidence that two distinct sub-domains arise during embryogen-
esis, namely the central and peripheral retina (Venters et al., 2013). The
central retina has previously been shown to be derived from distal optic
vesicles, where upon invagination they displace to the back of the eye
and form the central retina (Shin and O'Brien, 2009). In 2015, Venters
et al. further described the subdivision in the neural retina between the
central and peripheral retina. There is notably a variety of character-
istics that distinguish between the central and peripheral retina, with an
obvious distinction being the different photoreceptor densities found
within the central and peripheral retina, with cones predominantly
found in the central and rods in the peripheral retina (Venters et al.,
2015). In this review we will use the terminology of Polyak (1941) for
the human retinal regions (see later).
2.3. Anatomical differences between the central and peripheral retina: cells,
layers, and regions
2.3.1. Cells
The human retina, like all mammalian retinae, is made up of five
major cell classes of neurons: photoreceptors, bipolar cells, ganglion
cells, horizontal cells and amacrine cells, which are subdivided into
approximately 60 molecularly and morphologically distinct types. The
simplest circuit begins with the photoreceptors, which transduce light
into electrochemical signal and connect to the bipolar interneurons.
These in turn contact ganglion cells, which transmit signal to the brain.
Human retina has ∼100 million rods (active in dim light) and 4.6–6
million cone photoreceptors (active in bright light) and 1.0 to 1.5
million ganglion cells, implying a tremendous level of signal compres-
sion. At the same time, there are at least 13 bipolar cell types that split
signals at the photoreceptor synapse into multiple parallel pathways,
each with distinct functions, for transmission to the brain. Horizontal
cells and amacrine cells are interneurons that establish lateral interac-
tions at the first (photoreceptor → bipolar) and second (bipolar →
Fig. 1. Illustration of the major landmarks in the retina.
The left image illustrates the different structures of the retina and their position (Modified from Cybersight, Interpretation of Stereo Ocular Angiography: Retinal and
Choroidal Anatomy (Santini, 2017). The right image is an Optomap image taken from the Reykjavik Study and adapted to display the location of the various
structures on the retina. (MP=Mid-periphery and FP= Far-periphery).
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ganglion cell) synapse. In addition to neurons are glial cells, specifically
the Müller cells that span the retina from the inner surface to external
limiting membrane (a series of junctional complexes), astrocytes in the
nerve fibre layer, and microglia that reside in inner retina for surveil-
lance. The RPE is simple cuboidal epithelium that provides essential
support services to the photoreceptors on its apical aspect and the
choriocapillary (ChC) endothelium on its basal aspect. The retina has a
dual vasculature, with the attendant vascular endothelium and peri-
cytes – the intrinsic retinal circulation supplying the inner retina in-
cluding the internal part of the Müller cells, and the choroidal circu-
lation supplying the RPE, photoreceptors, and external portion of the
Müller cells. Between RPE and ChC is a laminated sub-endothelial ex-
tracellular matrix called Bruch's membrane (BrM), which functions as a
vessel wall laid out flat, in parallel to vascular lumens, rather than
circumferentially around them.
2.3.2. Layers
Retinal layers have been named by several schemes; the nomen-
clature of Polyak is widely accepted (Fig. 2) (Polyak, 1941). Retinal
layers vary markedly by region. Fig. 2 shows the neurosensory retina at
three locations in the central retina and one in the peripheral retina.
The macula, a 6-mm-diameter area centred on the fovea, comprises
numerous clinically relevant layers, sublayers, and potential spaces. As
classically described (B. B. Boycott, 1969; Hogan et al., 1971; Polyak,
1941), these include (from inner to outer) the RNFL, ganglion cell layer
(GCL), inner plexiform (synaptic) layer (IPL), inner nuclear layer (INL
with bipolar, horizontal, amacrine and Müller cell bodies), outer
plexiform (synaptic) layer (OPL), outer nuclear layer (ONL, with pho-
toreceptor cell bodies), photoreceptor inner and outer segments (IS, OS;
Polyak's bacillary layer), and RPE. The macular OPL has sublayers of
bipolar and horizontal cell neurites, cone pedicles and rod spherules,
and Henle fibres (photoreceptor axons and Müller cells). Photoreceptor
IS have myoid and ellipsoid compartments. Choroidal layers include the
inner and outer BrM, the ChC, and the choroid, delimited from the
sclera by the lamina suprachoroidea. Stereotypic extracellular deposits
accumulate with aging and age-related macular degeneration in the
subretinal space (subretinal drusenoid deposit), between the RPE and
its basal lamina (basal laminar deposit), and between the RPE basal
lamina and the inner collagenous layer of BrM (drusen).
2.3.3. Regions
According to the terrain theory of vision (Hughes, 1977), the sam-
pling of visual space by neurons in each species' retina is influenced by
the species’ normal habitat. Mammalian retinae have an area of high
neuronal density specialised for visual acuity, onto which images are
registered by coordinated head and eye movements (Wassle and
Boycott, 1991). A well-known example of this principle is the visual
streak of rabbits (Vaney, 1980), in which numerous ganglion cells align
horizontally for optimal surveillance of predators. Conversely, neuronal
density and spatial resolution is low in peripheral retina, because the
peripheral retina has other important functions, i.e., specialization for
movement detection and sensitivity, and the part of the visual brain
processing this information can be limited in size. Further, the level of
convergence from photoreceptors to ganglion cells is high in the per-
iphery, which contributes to lesser acuity and enhances movement
detection.
Polyak (1941) defined the human retinal regions as concentrically
organized around the visual axis in the fovea and based it on retinal
neurobiology in humans and macaques, especially the topography of
retinal ganglion cells and the local rod: cone ratio. The Henle fibre layer
(fibres of cones, rods, and Müller cells) is present in para- and perifovea.
The given diameter is for the region in humans (of unspecified ages).
The radius of the outer boundary is distance from the fovea:
• foveola, 350 μm (175 μm radius), absent ganglion cells;• foveal floor, 400 μm (200 μm radius), absent ganglion cells;
Fig. 2. Thickness of human neurosensory retina
varies by region.
N, nasal fovea; T, temporal to fovea. 1, 2, and 3mmN
pertain to parafovea, perifovea, and near periphery,
and 13mmT is extreme periphery, in the termi-
nology of Polyak (1941). 88-year-old female donor
with normal retina,< 6 h death-to-preservation,
post-fixed with osmium tannic acid para-
phenylenediamine, 0.8 μm epoxy sections, stained
with toluidine blue; original at http://projectmacula.
cis.uab.edu/. NFL, nerve fibre layer; GCL, ganglion
cell layer; IPL, inner plexiform layer; INL, inner nu-
clear layer; OPL, outer plexiform layer; HFL, Henle
fibre layer; ONL, outer nuclear layer; ISm, inner
segment myoid of photoreceptors; ISe, inner segment
ellipsoid of photoreceptors; OS, outer segments of
photoreceptors. The abundance of ganglion cells and
cone photoreceptors in addition to the Henle fibre
layer distinguish the macula from the periphery. Ar-
rows indicate a single continuous row of cone nuclei
in the parafovea. Some cell bodies in GCL and INL are
edematous (vacuolated).
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• parafovea, 2500 μm (1250 μm radius), 5–8 rows of ganglion cells; 1
rod between cones• perifovea, 5500 μm (2750 μm), 4 rows of ganglion cells diminishing
to 1 row; 2 rods between cones;
In addition to these macular regions, which are still used today,
Polyak also defined regions of peripheral retina on the basis of ganglion
cell density. These are not clinically detectable with current technology
but are described here for completeness:
• near periphery, 8500 μm (4250 μm radius); single continuous row of
ganglion cells; 2–3 rods between cones; mid-periphery, 14,500 μm
(7250 μm radius); discontinuous row of ganglion cells; 3 rods be-
tween cones;• far periphery, 26,000 μm (10,000 μm temporal, 16,000 μm nasal);
widely separated ganglion cells; extreme periphery, to the ora ser-
rata.
The entire expanse of human retina is ∼43mm from ora serrata to
ora serrata. The human macula, 6 mm in diameter, is thus defined as an
area with a continuous layer of ganglion cells (Polyak, 1957) and in
epidemiology as the area included in the Early Treatment of Diabetic
Retinopathy Study grid for grading colour fundus photographs (Early
Treatment Diabetic Retinopathy Study Research Group, 1991b). The
macula constitutes ∼3% of the total retina area (of ∼1000mm2),
leaving 97% of retina considered extramacular. Indeed, human per-
ipheral retina can be described as a generic mammalian retina that
lacks features that are specific to the macula.
In 1990, comprehensive 2-dimensional maps of cone and rod den-
sity in short post-mortem retinae prepared as unstained whole mounts
(Curcio et al., 1990) visualized the topography and morphologic detail
of inner segments. With accurately localized centres and computerized
microscopy, it was possible to determine photoreceptor density over the
entire retina (Fig. 3). The human macula was shown to be overall nu-
merically rod-dominant, including a rod-dominant perifovea sur-
rounding a cone-only foveola (0.8 mm in diameter). The foveola had a
high peak density of cones (> 150,000mm2) and a sharp decline with
eccentricity. Rods were also numerous (peak> 150,000mm2) in an
elliptical crest at 2–5mm eccentricity (i.e., along the macular peri-
meter) that encircled the optic nerve head nasally, with a hot-spot in
superior retina (Curcio et al., 1990) (Fig. 3). Outside the macula, cones
were 40% more numerous nasally than at corresponding eccentricities
in temporal retina. The highest ratio of rods to cones was 25–30 at
6–14mm eccentricity, because cones continued to decrease across the
retina more rapidly than did rods, except for nasal quadrant, where this
ratio was ∼20 due to a less step decline. Cone density is increased at
the nasal ora serrata, as previously seen (Osterberg, 1935).
Similar tissue, microscopy, and computational approaches were
recently applied to cell density and autofluorescence of human macular
RPE (Ach et al., 2014). A demonstrated peak cell density of ∼7200 RPE
cells/mm2 and a shallow eccentricity-dependent decline was consistent
with previous literature (Gao and Hollyfield, 1992; Snodderly et al.,
2002). With photoreceptor and RPE maps represented in a unified co-
ordinate system, it is possible to represent the phagocytic load on RPE
by a ratio of photoreceptors (cones + rods)/mm2 to RPE/mm2. This
ratio is high (≥28) at the foveal cone peak and lower in the parafovea
(13), rising to 29 at the edge of the macula, in human and non-human
primate (Curcio, 2018; Snodderly et al., 2002). These quantitative data
do not support a widely-held belief that higher phagocytic load on RPE
renders the macula uniquely vulnerable to age-related disease. In the
macula, RPE cell bodies, excluding the apical processes, are ∼14 μm
tall and the centre-to-centre spacing of these hexagonal cells is 13, 15,
and 16 μm in fovea, perifovea, and near-periphery, respectively (Ach
et al., 2014; Curcio et al., 2011). At the periphery, cells are flatter and
can be as wide as 60 μm (Harman et al., 1997).
The RPE cells are supported by BrM, an extracellular matrix that can
be defined as penta-laminar (if both basal membranes of the RPE and
ChC are considered), or trilaminar (if only the inner and outer col-
lagenous layer and the elastic layer are considered). Histological ex-
amination of BrM of older eyes at the peripheral and central retina
showed that the basal membranes of ChC are similar in the macula and
periphery (Johnson et al., 2007). Both geographic locations showed
significantly increased collagen fibril density and accumulations of
extracellular lipoprotein-like material and proteins eventually with age
(Booij et al., 2010) leading to impaired nutrient flow and clearance of
remnants of the phagocytosed photoreceptor outer segment debris.
Neurons of the inner nuclear and ganglion cell layers are numerous
and are displaced from the foveal centre to create the foveal pit (Fig. 3)
(Provis et al., 2013). Approximately 95% of macular ganglion cells are
midget cells, i.e., compact neurons responsible for transmitting signal
for high acuity and colour vision to the brain (Dacey, 2000). Mapping
studies using the same methods used for photoreceptors described
above have shown at least 2 ganglion cells for each foveal cone within
the central several degrees of vision (Curcio and Allen, 1990; Dacey,
1993; Watson, 2014). Each foveal cone contacts two midget bipolar
cells, splitting the output signal along “private lines” signifying light ON
and light OFF to corresponding midget ganglion cells (Calkins et al.,
1994). This unique circuitry means that 40% of human retinal ganglion
cells are laterally offset from their corresponding photoreceptors in the
centres of their receptive fields in visual space (Curcio et al., 1990). The
Henle fibre layer thus comprises 14% of retinal thickness in the macula
and contains inner fibres of rod and cone photoreceptors (interleaved
with Müller glia and up to 600 μm long) extending centrifugally to
contact bipolar neurons (Drasdo et al., 2007; Perry and Cowey, 1988;
Polyak, 1941). Outside the macula, ganglion cells are reduced in den-
sity (by a 40:1 gradient) but are 3 times more numerous in nasal
quadrant than in temporal quadrant, resembling a visual streak. High
concentration of macular ganglion cells is responsible for the high
proportion of visual cortex (primary and secondary areas) devoted to
central vision. Müller glia span the retina between external and internal
limiting membranes. In the macula Müller cells equal or exceed the
number of foveal cones (Burris et al., 2002) and are Z-shaped due to the
Henle fibre layer. Extra-macular Müller cells are vertical and out-
numbered by photoreceptors.
In the periphery, the retina is thinner and less elaborate in structure,
and neurons increase in size and become scarcer (see Fig. 2). Greater
convergence of photoreceptor signal into interneurons allow summa-
tion of signal from more photoreceptors and thus permit a response to
weak visual stimuli. The emergence in the late 1980's of cell-type
specific markers and techniques for dye-filling with electrodes meant
that retinal neurons could be studied as entire populations, where new
properties emerged such as cooperative tiling of visual space (i.e., fit-
ting dendritic fields together for efficient coverage) (Wassle and
Boycott, 1991). These studies showed eccentricity-dependencies that
had implications for spatial vision, e.g., ganglion cells increased in
dendritic field area with distance from the fovea (Dacey, 1993; Dacey
and Petersen, 1992), maintaining the tiling so that spatial density de-
creased (cells/mm2). Other studies in macaque retina, which are similar
to human in many ways, have shown eccentricity-dependent density
declines specific for each cell type as identified with molecular markers
(e.g., displaced amacrine cells (Wassle et al., 1989), midget bipolar cells
(Wassle et al., 1994), AII amacrine cells (Wassle et al., 1995), and
horizontal cells) (Wassle et al., 2000). Thus the peripheral retina is
exemplified by divergence of cone signal to multiple bipolar classes
(Chun et al., 1996) whereas the macula includes this level of divergence
plus the private lines of the midget system. Thus, in the fovea centre,
there are 3.5 bipolar cells per cone. This ratio is at least 2 out to 5mm
eccentricity (10° in a monkey) (Martin and Grunert, 1992).
2.4. Molecular differences between the central and peripheral retina
Alongside the morphological differences, there is an increasing
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knowledge base about the molecular differences between the central
and peripheral retina (see for reviews (Li et al., 2017; Tian et al.,
2015)). Comparison of gene expression between the macula and per-
iphery has been investigated by several studies both in human and in
animal models which lack maculae but do have centre-to-peripheral
gradients of neuronal densities (Al-Hussaini et al., 2016; Cai et al.,
2012; Ishibashi et al., 2004; Kociok and Joussen, 2007; Li et al., 2014).
Li et al. showed that 2000 differentially expressed genes between
macular and peripheral retina, using human post-mortem tissues with
less than 6 h' post-mortem time (Li et al., 2014). Genes expressed at
significantly higher levels in the macular area include genes involved in
lipid metabolism, ion transport, neuronal differentiation, regulation of
transcription, cell adhesion, cell motility and differentiation. Con-
versely genes expressed at significantly higher levels in the peripheral
retina were those involved in the Wingless-type MMTV integration site
family (Wnt) receptor signalling pathway. Wnt signalling controls many
events during embryogenesis, exerts significant regulation of cell mor-
phology, proliferation, motility and cell fate (Cai et al., 2012). Inhibi-
tion of the Wnt pathway is correlated with preventing cells from
moving into a regenerative state, and Wnt signalling is crucial in trans-
differentiation of ciliary margin stem cells into neural retina at the
ciliary marginal zone (Cai et al., 2012). Alongside the transcriptomic
changes, differences in protein levels have also been investigated.
Proteomic studies have highlighted the differential protein distribution
and the differential change with disease progression (Ethen et al., 2006;
Okamoto et al., 2010). A comparison of protein expression between the
macula and peripheral retina has concluded that arrestin-C and
3′(2′),5′-bisphosphate nucleotidase 1 are highly expressed in the ma-
cular region compared to the periphery. This is thought to be due to the
fact arrestin-C is located in photoreceptor outer segments and the outer
plexiform layer, while 3′(2′),5′-bisphosphate nucleotidase 1 is highly
expressed in cone photoreceptors which are most dense in the macular
area (Okamoto et al., 2010). The proteome of the human eye, especially
the retina, is now under intense investigation and promises to be hot
topic for the years to come (Zhang et al., 2015). This is due to the
increasing sensitivity of mass spectrometric approaches, which in turn
will allow a more precise definition of the proteomic landscape of the
retinal layers and in fact the whole eye (Zhang et al., 2016).
There are difficulties as well when one wants to compare gene ex-
pression with protein expression. For example, when epidermal fatty
acid binding protein (E-FABP) gene expression was compared between
peripheral and macular RPE in humans using a comparative tran-
scription study, E-FABP was found to be 6.3 fold higher in the per-
ipheral RPE (Umeda et al., 2003). This, however, differs from the in-
vestigation of the proteomics of the macular and peripheral retina
(Zhang et al., 2015). In addition, immunohistochemical labelling of E-
FABP showed that the protein is in the neurosensory retina, but not in
the photoreceptors, while the gene expression change was associated
with the RPE (Umeda et al., 2003). With improving methodologies and
with the availability of better preserved tissues, analysis is now being
carried out for lipids (Anderson et al., 2014; Thompson et al., 2015;
Zemski Berry et al., 2014), small molecules (Ablonczy et al., 2013),
molecular ions (Thomson et al., 2015) and trace elements (Flinn et al.,
2014) which will refine the molecular understanding of differences
between central and peripheral retina in both health and disease at
these geographic locations.
A key molecular difference between the macula and peripheral
human retina is the distribution of specialised macular pigments. The
Fig. 3. Photoreceptor and ganglion cell topography in adult human retina. (Modified from Curcio et al. (Curcio and Allen, 1990; Curcio et al., 1990) Maps of cells/mm2
represent a composite of at least 5 donor eyes. Colour bars show cells (x1000) per mm2 in linear scales for A, D, E, and F and in non-linear scales to show peripheral
retinal contours in B, C. Increments of colour bars are (A) 12,500; (B) 1000; (C) 500 cells/mm2, then 1000 cells/mm; (D, E) 12,500; (F) 2500.
A. Rods are most numerous superior to the macula and in a nasally-extending, horizontally-oriented elliptical ring (rod ring) that extends around the optic nerve
head. Rods outnumber cones 20:1 overall. The small map relative to cones and to rods is due to the difficulty of mapping rods in far peripheral retina. B. Cones are
40% more numerous in the nasal periphery than at corresponding eccentricities in the temporal periphery. There is a nasal rim of higher cone density. C. Ganglion
cells are 3-fold more numerous in the nasal periphery than in corresponding areas of the temporal periphery. D. Rods are absent from the rod-free foveola, (0.350mm
diameter). E. Cones are predominant in an area 0.8mm in diameter. The point of highest density is in a<50 μm-diameter area corresponding to the central bouquet.
F. Ganglion cells are most numerous in a horizontally oriented elliptical ring, cresting at 0.8mm eccentricity. They are largely absent from the foveal floor.
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xanthophyll pigments lutein, zeaxanthin, and meso-zeaxanthin are
highly concentrated in the fovea (Bernstein et al., 2016), decline by an
order of magnitude within 2° of fixation, reach very low levels at the
edge of the macula, and remain low throughout the retina (Bone et al.,
2001; Hammond et al., 1997; Snodderly et al., 1984). The distribution
can be envisioned as 3 concentric zones centred on the fovea: zeax-
anthin is central-most (foveola, 350 μm diameter), overlapped by meso-
zeaxanthin (foveal avascular zone, 500 μm diameter); these two sur-
rounded by lutein (foveal-parafoveal annulus of outer diameter,
2.0 mm) (Nolan et al., 2016). The role of xanthophyll pigments in vision
is investigated under several mechanistic hypotheses - anti-oxidant
protection against blue light damage (Loane et al., 2008), enhanced
visual performance and visual comfort by reducing chromatic aberra-
tion and light scatter (Nolan et al., 2011; Stringham et al., 2015), and
enhanced neural efficiency hypothesis by direct interaction with neu-
rons (Renzi and Hammond, 2010). Xanthophyll pigments are also found
in the brain and studied in reference to cognition and aging (Erdman
et al., 2015; Mohn et al., 2017). Dietary supplements containing lutein
and zeaxanthin are recommended for patients with intermediate AMD
(Age-Related Eye Disease Study 2 Research Group, 2013).
Recent evidence supports macular Müller cells as the principal
cellular reservoir of xanthophylls. High concentration in the Henle fibre
layer, foveal centre, and inner plexiform layer is well explained by the
morphology of individual Müller glia (Bringmann et al., 2018; Curcio,
2018; Snodderly et al., 1984). The finding of rings and shoulders in
addition to a strong central peak is consistent with Müller cell side
branches in the synaptic layers (Delori et al., 2006; Dietzel et al., 2011).
In 1984 Snodderly et al. attributed strong xanthophyll signal in the
Henle fibre layer to cone axons, a description which overlooks the
numerous rod and Müller processes also in this layer (Curcio et al.,
1990; Perry and Cowey, 1988; Snodderly et al., 1984) and is often
mistakenly taken to mean that these pigments localize to only cone
axons. In macular telangiectasia type 2, xanthophyll absence is
associated with histologically confirmed degeneration of foveal Müller
cells (Powner et al., 2010, 2013). Patients with Sjögren-Larsen syn-
drome exhibit loss of clinically detectable xanthophyll and presence of
inner retinal cysts suggestive of Müller cell degeneration (Theelen et al.,
2014; van der Veen et al., 2010). Surgically excised lamellar hole as-
sociated epiretinal membranes are enriched both in Müller cell markers
and in xanthophylls (Obana et al., 2017; Pang et al., 2016). Clinical
imaging suggests that xanthophylls persist in central geographic
atrophy (Dysli et al., 2016; Sauer et al., 2018; Sunness et al., 1999),
even after photoreceptor death, because Müller cells remain (Li et al.,
2018). It has been suggested that HDL-mediated delivery of xantho-
phylls through the RPE is a physiologic activity that contributes lipids
to the formation of soft drusen in advanced age (Curcio, 2018).
The ratio of lutein to zeaxanthin within 0.25mm of the fovea is
approximately 1:2.4 with this reversing in the retinal periphery where
the ratio is 2:1 between 8.7 and 12.2mm from the fovea (Bernstein
et al., 2010). There is a 100 fold drop in the concentration of macular
pigment in the peripheral retina compared to the macula, although
levels vary considerably between individuals (Bartlett et al., 2010).
The principal signal source for clinical autofluorescence imaging is
RPE lipofuscin and melanolipofuscin. These are numerous lysosome-
related, long-lasting inclusion bodies that are detectable in human RPE
starting in childhood (Feeney, 1978). Throughout adulthood, the RPE
continues to accumulate lipofuscin both in the central and peripheral
retina. The topography of histologic autofluorescence matches that of
photoreceptors (Ach et al., 2014; Curcio et al., 1990; Wing et al., 1978),
i.e., high in a rod-dominated crest at the edge of the macula and present
but not absent in the fovea. RPE lipofuscin has been postulated as
central to many deleterious events in AMD, including phototoxicity-
mediated cell death and drusen formation (Sparrow et al., 2002; Wu
et al., 2010), primarily through studies of cultured cells exposed to A2E,
a bisretinoid derivative of vitamin A. A2E was originally isolated from
whole human eye cups (Eldred and Lasky, 1993), from which it is
Table 1
Illustrates the key differences between the central and peripheral retina.
Central Retina Peripheral Retina
Bruch's membrane Thin (2–4 μm), acellular, five-layered extracellular matrix located
between the retina and choroid (Christine and Curcio, 2012; Hildebrand
and Fielder, 2011)
Half as much accumulation of lipoprotein-like material than central. It
is approximately 1-2μm in thickness nearing the ora serrata
(Hildebrand and Fielder, 2011).
Retinal Pigment Epithelium
(RPE)
RPE cells have a peak density of 7500 cells/mm2 at the fovea (Ach et al.,
2014)
They have a density of 2000 cells/mm2. (Boulton and Dayhaw-Barker,
2001)
Photoreceptors Measures approximately 6mm in diameter centred on the fovea. Rods
are absent in the fovea and are only present in the central retina in an
elliptical ring that passes through the optic nerve. Around 50% of the
retinas cone photoreceptors are present in the central 30° of the retina
(Curcio et al., 1990; Kolb, 1995).
Stretching to the ora serrata the peripheral retina is approximately
21mm measured from the centre of the fovea. It accounts for around
92 million rods. The cone-to-rod ratio in human retinas is
approximately 1:20 (Curcio et al., 1990).
Outer nuclear layer (ONL) Similar thickness in central and peripheral retina. In the central retina
cones have oblique axons displacing their cell bodies (Kolb, 2005)
Similar thickness in central and peripheral retina. In the peripheral
retina the rod cell bodies outnumber the cone cell bodies while reverse
is true for the central retina (Kolb, 2005)
Outer plexiform layer (OPL)
and Henle fibre layer
The OPL is thickest in the macula and associates with the Henle fibre
layer (a pale staining fibrous like area present in the central retina due to
fibres of cones and rods and accompanying Muller cell processes) (Kolb,
1995; Perry and Cowey, 1988; Polyak, 1941)
Thinner and no Henle fibre layer is present.
Inner nuclear layer (INL) Thicker due to greater density of cone-connecting second-order neurons
(cone bipolar cells, horizontal cells and amacrine cells) (Kolb, 2005)
Thinner due to the decreased density of cone photoreceptors (Kolb,
2005)
Inner plexiform layer (IPL) Thicker due to high number of ganglion cells making connections in this
layer.
Thinner due to the decreased density of the ganglion cells towards the
periphery
Ganglion cell layer (GCL) Densely packed and often numerous layers of ganglion cells. Density
levels reach 32,000–38,000 cells/mm2 in a horizontal elliptical ring
0.4–2mm from the fovea (Curcio and Allen, 1990).
GCL density drops by 35,000 to 5,000 cells/mm2 within 4mm of the
fovea with this dropping again from 4mm to the ora serrata by 5000
to 200-300 cells/mm2 (Curcio and Allen, 1990)
Nerve fibre layer (NFL) Thicker in the central retina and continues to thicken towards the optic
disc due to convergence of retinal ganglion axon fibres on the optic disc
(Kolb, 2005).
Thinner and difficult to recognize. (Kolb, 2005)
Macular Pigment Mass ratio of Lutein to Zeaxanthin is approximately 1:2.4 (0–0.25mm)
(Bernstein et al., 2010)
Mass ratio of Lutein to Zeaxanthin 2:1 (8.7–12.2mm) (Bernstein et al.,
2010).
Gene Expression Neurofilament 3 (NEF3), Light neurofilament (NEFL), Brain-specific α-
tubulin (TUBA3), α-tubulin (ᴋ-α-1), Β-tubulin (FKBP1A) (Sharon et al.,
2002)
Rhodopsin(RHO), β and γ subunits of transduction (GNB1 and
GNGT1), β and γ subunits of rod cGMP-phosphodiesterase (PDE6B and
PDE6G), α subunit of the cGMP-gated cation channel (CNGA1), and
recoverin (RCV1) (Sharon et al., 2002)
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difficult to detect macula-specific signals. Recent data using assays with
higher spatial precision have indicated that A2E is sparse in the macula
and abundant in the periphery (Ablonczy et al., 2013; Adler et al.,
2015; Anderson et al., 2017; Bhosale et al., 2009; Pallitto et al., 2015;
Zemski Berry et al., 2014), in humans and in non-human primates,
raising the question of what fluorophore(s) account for macular auto-
fluorescence signal. Table 1 shows differences between the central and
peripheral retina.
2.5. Functional differences between the central and peripheral retina
When referring to peripheral vision, we refer to the vision mediated
by the photoreceptors within the “peripheral” retina. These special
features of the fovea as outlined earlier (section 2.3) enable high spatial
resolution, low spatial summation, poor scotopic vision but excellent
photopic vision, whereas the peripheral retina, which is rod-dominant,
enables excellent scotopic vision, high spatial summation but poor
spatial resolution.
From a functional/psychophysical perspective, peripheral vision is
usually considered to be any point outside the central 1.7° field of vision
(i.e. rod-free fovea) (Rosenholtz, 2016). Far peripheral vision has been
designated as beyond 60° as this is the approximate value for occlusion
by the nose and eyebrow. (Simpson, 2017). Other regions such as
8°–30° for near peripheral vision and 30°–60° for mid-peripheral vision
have been used in the literature (Simpson, 2017) though these desig-
nations are not solidly linked to anatomy (Section 2.3), but rather have
developed through convention.
An often-overlooked feature of the retina in the far periphery is the
existence of a cone-rich rim, a 1mm strip adjacent to the ora serrata in
which cones predominate rather than rods (Mollon et al., 1998;
Østerberg, 1937). Mollon et al., postulated that it may be important for
detecting sudden movements, measuring optic flow, contributing to
colour constancy or involved in modulating circadian rhythms (Mollon
et al., 1998). However, given that a similar cone-rich rim is also present
around the optic disk it could be argued that it should not be assumed
that there is a significant functional role of such anatomical features
(Curcio et al., 1990).
Peripheral vision has a different role in visual perception than
central vision. This is due to the peripheral retina's ability to detect
movements via the wide dendritic trees of the peripheral ganglion cells,
while the fovea is poor in movement detection but high in distin-
guishing details because of the small dendritic trees of the ganglion cells
at this location (Walls, 1963). Contrast sensitivity beyond 70° has been
shown to the higher to moving stimuli than stationary (To et al., 2011).
Peripheral vision compensates for the lack of high acuity by the area it
covers (Larson and Loschky, 2009). Patients more quickly understand
and process low-detailed stimuli like a big shape with a uniform
“bland” colour when using their peripheral vision than when they were
limited to using their central vision only. Furthermore, blocking out
peripheral vision in order to mimic vision loss in the peripheral retina
correlated to a dramatic slowing of this “low-detail” processing (Larson
and Loschky, 2009).
Peripheral vision also participates in a phenomenon termed “scene
gist recognition” or perception without awareness (Larson and Loschky,
2009). Peripheral vision has been shown to be more important than
central vision for an individual's awareness of their surroundings, even
when the environment is highly detailed or has high spatial frequency
(HSF) information that could not be fully resolved by the peripheral
retina. This is extremely interesting, because perception of HSF stimuli
is generally associated with central vision. (Musel et al., 2011). But
experiments illustrate that even in highly detailed environments, in-
dividuals primarily rely on peripheral vision for awareness and re-
cognition of their settings (Ramanoel et al., 2015). This principle ap-
plies both to perception of natural settings containing low spatial
frequencies and urban settings containing higher spatial frequencies
(Musel et al., 2013).
The more we understand about peripheral vision, the more we un-
derstand its importance in understanding an individual's engagement
with their environment. Numerous studies illustrated the importance of
peripheral vision in attention processing tasks (Desapriya et al., 2014;
Ludwig et al., 2014). One study comparing children with normal vision
with those with poor peripheral vision found that the latter group had
slower visual scanning and impaired motion detection, concluding that
reduced peripheral vision in children can have a large impact on normal
development (Huurneman et al., 2014). Most importantly, children
with peripheral visual deficits performed significantly worse on tasks
that required visual attention than the normal vision peers and children
with poor central vision (Tadin et al., 2012). This correlation between
peripheral visual deficits and attention tasks isn't surprising. Most stu-
dies on elderly also find that peripheral vision is important in driving
and postulate that peripheral visual health is a much better predictor of
driving ability than visual acuity (Huestegge and Bockler, 2016; Peli
et al., 2016). Furthermore, studies have implicated peripheral visual
deficits as a larger cause of pedestrian accidents in dementia patients
than cognitive impairment alone (Owsley and McGwin, 2010).
Peripheral visual health is vital in the aging population and not only
for driving (Fisk and Mennemeier, 2006; Fisk et al., 2002; Wolfe et al.,
2017). Peripheral visual function has a more pivotal role than central
vision in mobility, locomotion, and postural stability (Black et al., 2008;
Marigold, 2008; Nakayama, 1985; Vargas-Martin and Peli, 2006).
Therefore, maintaining and monitoring peripheral vision is likely to
become a crucial factor for determining if an individual can live in-
dependently. Lack of understanding and monitoring peripheral visual
function both in clinical and in everyday settings can have deleterious
consequences in a population where the majority is elderly. Despite
growing evidence of its importance in daily living, very little research
has been carried out to date to explore the effects of retinal pathologies
on peripheral visual function and this should be given more attention.
Further consideration of the role of far peripheral vision has been given
in a review by (Simpson, 2017).
2.6. Pathological differences between the central and peripheral retina
A major contribution to the literature on peripheral retina are 17
publications of Foos, Lewis, Straatsma, and colleagues (1967–1986).
These studies outlined a systematic and quantitative characterization in
1191 eyes recovered from 631 individuals at autopsy. Particular at-
tention was paid to ex vivo macrophotography prior to paraffin his-
tology, and the resulting imaging-histology correlations are valuable for
elucidating today's wide-field imaging. Here we summarize findings on
pigmentary change and drusen. An early demonstration of the fineness
of histologic detail potentially available to clinical imaging, these data
represent an informative comparison to macular changes associated
with Age-related Macular Degeneration (AMD). Although AMD affects
primarily central vision, it is important for understanding the under-
lying biology to appreciate the degree to which peripheral retina is also
affected.
2.6.1. Pigmentary changes
At the ocular equator and anterior to it, 7 macroscopically defined
patterns of pigmentary change were identified and characterised by
topography and histology (Bastek et al., 1982).
All increased in prevalence across the lifespan. Virtually all older
eyes had one or more of these morphologically distinct degenerations.
By affected location, these patterns were divided into 3 groups.
Reticular degeneration of RPE is shown in Fig. 4.
Affecting the retina: Linear, a sharply demarcated radial pattern of
black pigment adjacent to the inner retinal surface at the ora serrata,
corresponding to RPE of the pars plana extending along the inner aspect
of the retina. Dusting, a coarse, sprinkled pattern of red-brown pigment
in the retina, corresponding to intracellular pigment accumulations of
varying size, throughout the retinal layers. Spicular, a bone spicule
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pattern of black pigment usually aggregated around blood vessels in
middle and inner layers (like retinitis pigmentosa (Li et al., 1995)).
Affecting the RPE: Granular, a discrete pattern of small pigment
aggregations, corresponding to variable cell size and pigmentation.
Clumping, discrete large pigment aggregations, due to heterogeneity in
cell size and pigmentation correlating with hyperpigmented and hy-
popigmented areas. Reticular, a fishnet-like pattern of linear pigment
aggregations that branched and formed incomplete or complete 5 or 6
sided polygons, with internal hypopigmentation, and associated with
lines of hard drusen (Fig. 4A–C). Hyperpigmented lines corresponded to
RPE cells that were tall and relatively thick, increased in pigment
content, and occasionally heaped up into multilayers. Effaced and hy-
popigmented RPE overlay drusen, and hyperpigmented and occasion-
ally heaped RPE surrounded drusen bases (Fig. 4D–F).
RPE and choroid: Tapetochoroidal hypopigmentation, a distinct
band of decreased pigmentation of RPE and choroid, located cir-
cumferentially at the equator, corresponding to a diffuse diminution in
size and pigmentation of RPE cells.
Reticular degeneration of RPE (RDPE) was first described clinically
by Haab in 1901 (Lewis et al., 1985), and due to its associations with
genetics and macular pathology, this entity merits re-visiting today.
Gass described and illustrated RDPE in a series of 200 older persons,
noting that 1/3 of eyes with AMD also had RDPE (Gass, 1972). This
association with AMD was confirmed (Humphrey et al., 1984) and
further shown to be significantly higher in AMD eyes than in age-
matched control eyes. Lewis et al. (1985) showed in a large autopsy
study and a parallel clinical series (n= 50) that RDPE was present in all
quadrants, involving the full circumference of the eye, with less in-
volvement in temporal retina. The age-increase (4.3% prevalence in
eyes< 50 years; 60% in eyes> 90 years), high degree of bilaterality,
and association with AMD changes in the same and fellow eyes were
notable features of RDPE. Lewis et al. speculated that RDPE was a
“zonal degeneration related to relative ischemia in the watershed area
of the antero-posterior choroidal circulation and the gradual decline
with aging in the metabolic activities of the RPE.”
Several studies showed that RDPE might signify genetic suscept-
ibility for AMD, perhaps even before AMD is visible in the macula.
Postel et al. (2005) found that in 411 singletons and 125 multiplex
probands stratified using standardized colour fundus photography,
RDPE was almost as common (50.6%, 41.0%, respectively) as RPE
hyperpigmentation (59.5%, 58.5%) and large drusen in the macula
(49.4%, 47.3%), two well-known ocular risk factors for progression.
These same authors (Shuler et al., 2008a) found that the proportion of
eyes with RDPE was significantly higher in carriers of the risk-con-
ferring Y402H allele of complement factor H (CFH, n=796) than in
non-carriers (n= 160). RDPE was the only one of 34 characteristics
that associated with this variant. In a sample of 2103 AMD patients,
Seddon et al. found that 25% of eyes had RDPE and that this percentage
increased with AMD severity by standardized colour fundus photo-
graphy (Seddon et al., 2009). There was a two-fold greater risk of
maculopathy in eyes with RDPE, even in those eyes at low AMD grades.
Other tested genes did not exhibit this association, and interestingly the
risk allele of ARMS2 was inversely related to RDPE.
2.6.2. Drusen
S.H. and J.P. Sarks, with M.C. Killingsworth, contributed founda-
tional AMD pathology, including drusen heterogeneity, in studies uti-
lizing transmission electron microscopy of affected maculae from
Fig. 4. Reticular degeneration of the retinal pigment epithelium (RDPE).
Panels A–C show the RPE layer after the neurosensory retina is removed, in caps sliced off the equator of human globes at autopsy. Panels D–F show 6-μm-thick
paraffin sections (D, hematoxylin-eosin stain; E, F, periodic acid-Schiff stain); R, RPE; d, druse; yellow arrows, Bruch's membrane. Panels D, E are more highly
magnified than panel E (compare the sizes of erythrocytes across panels). Adapted with permission from (Lewis et al., 1985)
A. Panoramic view. Hyperpigmented lines form a netlike pattern, delineating a region of hypopigmented polygons. Incomplete polygons and branching hy-
perpigmented lines contain hard drusen. B. Detailed view. Hyperpigmented lines form a fishnet-like pattern, delineating a region of hypopigmented polygons. C.
Close-up view. Drusen (arrows) at the nodes of the fishnet of hyperpigmented lines are hypopigmented in the centre and hyperpigmented around the base. D.
Histologic section through a hyperpigmented line. RPE cells are tall and thick, with numerous pigment granules. Bruch's membrane appears thickened. Chor-
iocapillaries are intact. E. Dome-shaped hard drusen (d) in linear arrangement with hyperpigmentation and occasional heaping up of RPE cells surrounding them.
Choriocapillaries are intact. F. A section through the centre of a hypopigmented polygon shows confluent drusen (called soft) with hypopigmented, flattened, and
thinned RPE cells.
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clinically documented eyes of S.H. Sarks' patients. Studies definitively
localized drusen in the sub-RPE-basal laminar space and demonstrated
that risk-conferring soft drusen are dome- or mound-shaped with
sloping sides and filled with ‘membranous debris’ implying abundant
lipids (Sarks et al., 1980, 1994). However, drusen are numerous in
peripheral retina (Friedman et al., 1971; Lengyel et al., 2004), which is
large, and thus the majority of drusen are extramacular. Yet the macula
is more vulnerable to AMD.
This conundrum might be resolved if macular and extramacular
drusen had different molecular composition. The Sarks stated that soft
drusen localized exclusively to central macula (Sarks et al., 1996) but
did not provide supporting data. In particular, data indicating scarcity
or absence of soft drusen in the periphery could definitively establish a
relationship of these deposits with foveal biology, as postulated (Curcio
et al., 2013). Few published studies were designed to test this possibi-
lity. Lewis et al. using ex vivo imaging of RPE with retina removed,
paraffin histology, and evaluation in 14 defined regions (Lewis et al.,
1986a; b) illustrated macular and peripheral drusen in one figure. Fig. 5
panel C, H (modified from their papers) shows mound-like, confluent
“serogranular drusen” (a Sarks term) in macula. These were contrasted
to globular (‘hard’) drusen (Fig. 5D and E) and other drusen from the
periphery, also called soft (Fig. 5F and G). Although they are low
mounds, it is arguable whether these latter drusen are soft in the Sarks'
sense. Rather, the druse bases are not as circular as macular drusen
(compare panel C to B), paraffin histology and light microscopy are
suboptimal for assessing lipid, and the druse interior of panel H appears
mostly empty as though it was extracted. In a much smaller comparison
of macula and periphery (Rudolf et al., 2008b), drusen from 9 eyes of 7
AMD donors were micro-dissected and pelleted for high resolution
histology. This study found soft drusen only in the macula, where they
were also more likely to have overlying BLamD, continuous coverage by
RPE, and interiors dominated by a friable and homogeneous membra-
nous material consistent with the Sarks' descriptions. These suggestions
of regional differences in druse composition should be revisited and
tested with new histology and clinical imaging of the entire retina.
The genetic associations of peripheral drusen have been studied,
although with variable definitions for the regions, AMD stages, and
druse types. Peripheral drusen, defined as those anterior to the ocular
Fig. 5. Drusen in peripheral retina, in comparison to macula.
Retina is completely removed from retinal pigment epithelium (RPE) in A-B and partially in C. A. Temporal equatorial region in an eye with multiple extramacular
drusen, all hard. Soft drusen were not present. The macula also had multiple hard drusen. B. Temporal equator in an eye with multiple extramacular drusen.
Numerous hard, discrete soft and confluent soft drusen are present. C. Macular region of the same eye showing discrete and confluent soft drusen (teal arrow). A
remnant of retina remains and is attached at the optic nerve head. D. Contiguous hard drusen with a globular configuration (periodic acid-Schiff). E. Hard druse in
the peripheral fundus with minimal thinning of the overlying RPE and mild hyperpigmented borders (hematoxylin-eosin). F. Discrete soft druse with a dome-shaped
configuration and lightly staining material (hematoxylin-eosin). G. Confluent soft drusen, with vacuolated granular material between basal laminar deposit (ar-
rowhead) and the inner collagenous layer Bruch's membrane (arrow) (hematoxylin-eosin). H. A soft druse with apparent membranous debris (by the Sarks' definition,
teal arrow) in the macula. Thick basal laminar deposits are adjacent to the druse (between arrows) and also attached to the inner aspect of Bruch's membrane
(arrowhead). A nodular excrescence is noted on the inner side of Bruch's membrane (arrow). Calcification within the druse is also seen (asterisk; hematoxylin-eosin).
Adapted with permission from (Lewis et al., 1986b).
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equator, were more significantly common in multiplex than singleton
probands (22.8% vs 7.5%) (Postel et al., 2005). Neither variants in CFH
nor ARMS2/HTRA1 were associated with peripheral drusen or extra
macular drusen in a clinic-based study of 755 AMD patients; how
periphery and extra-macula were differentiated, however, was not de-
fined (Shuler et al., 2008a, 2008b). In contrast, a study of 2103 AMD
patients found a positive association of two CFH variants with periph-
eral drusen (i.e., located near the equator) with all severity levels of
AMD but not if only eyes early AMD were analysed (Seddon et al.,
2009). In a cohort of adults ≤67 years, the presence of drusen per-
ipheral to the vascular arcades was associated with the Y402H variant
of CFH, with a fourfold increase in the odds of drusen among subjects
homozygotic for Y402H compared with those in subjects without this
polymorphism. This association also held for macular drusen ≥63 μm
but not for numerous drusen ≤63 μm (Munch et al., 2010).
3. Historical development of peripheral retinal imaging
While imaging the fundus has been a standard for screening, de-
tecting and monitoring the presence of ocular diseases including the
systemic diseases that manifest in the retina, obtaining peripheral views
of the retina remained challenging due to the limitations imposed by
the physical properties of the eye. Since the production of the first re-
liable fundus camera by Carl Zeiss in 1926, imaging of the retina has
undergone several significant technical advances. Before the introduc-
tion of UWFI, traditional techniques provided adequate imaging of the
optic nerve and posterior pole, but a limited view of the retinal per-
iphery. With the introduction of modalities fit to capture the peripheral
retina, evaluation and documentation of the retinal periphery has be-
come more practical in a clinical environment. Below is a summary of
the methodologies used to examine and/or record peripheral retinal
pathology.
3.1. Retinal drawings
The first known method of wide-angle retinal illustration is thought
to be retinal drawings. The well-known ophthalmic artist Terry Tarrant
sketched retinal maps from 1958 to 1988, producing drawings of the
ocular fundus (Fig. 6). Drawings took from 30min to 3 h to map
pathologies on the retina, which included tears and retinal detachments
(Dvorak and Russell, 2011). He continued retinal drawings, even
though imaging techniques had been made available, to educate the
examiner in ocular anatomy and the use of imaging.
3.2. Indirect ophthalmoscopy
In 1900s Trantas (1900), used the indirect ophthalmoscope to view
the peripheral retina by indenting the sclera, through the upper lid over
the limbus, using the nail of his thumb to apply firm pressure. This
allowed him to visualize wider angle of the eye including examination
of the anterior part of the retina; the view was imperfect and the pro-
cedure was highly uncomfortable for the patient. An improvement in-
troduced by Schepens 50 years later refined the use of scleral in-
dentation while using his newly manufactured binocular indirect
ophthalmoscope, allowing visualization of the retina to the ora serrata
and into the pars plana (Schepens and Bahn, 1950).
3.3. Fundus imaging technique
Advancements in retinal imaging included Jackman and Webster
producing the first published human fundus photographs in the late
1800's (Jackman WT, 1886). The first known wide-angle camera, the
Equator-Plus camera was developed by Pomerantzeff in the 1970s. This
method used scleral trans-illumination coupled with a contact lens to
produce a field of view of approximately 148° (Pomerantzeff, 1975).
The introduction of fundus cameras in 1926 revolutionalised imaging of
the eye. Traditional fundus cameras can provide images of the per-
ipheral retina covering around 75° field of view by directing the ob-
jective lens to the periphery and at the same time asking the patient to
fixate eccentrically. Multiple photographs of the posterior pole from
different angles can be taken and subsequently montaged together. This
has been refined for the purpose of diabetic retinopathy (DR) clinical
trials in which a seven standard field (7SF) images are captured cov-
ering a field of view of approximately 100° (Lotmar, 1977). Montaging
images has several limitations including distortions in alignment,
magnification, or brightness between the retinal images. The ability to
accurately register images for longitudinal monitoring is technically
challenging when using montaged images. This capability is particu-
larly important for lesions such as choroidal nevi and tumours, where
careful longitudinal monitoring and measurements are required.
Fig. 6. Pathology detected on the ocular fundus.
A: example of retinal drusen on a retinal drawing; B: Optomap image showing
drusen on the retina; C: retinal drawing showing retinal tears and lattice de-
generation; D: Optomap image showing a lattice degeneration; E: retinal
drawing showing retinal haemorrhages and exudates; F: Optomap image
showing retinal haemorrhages; G: retinal drawing showing a retinal detach-
ment; H: Optomap image showing a retinal detachment.
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3.4. Retcam
The year 1997 saw the introduction of another wide field fundus
camera known as the RetCam II retinal imaging system (Clarity Medical
Systems, Inc, Pleasanton, CA). This portable camera requires the use of
a contact lens and allows for several different lens attachments. The
Retcam can produce retinal images up to 130° field of view. This
camera is primarily used for retinal imaging in children, such as
screening for retinopathy of prematurity, retinoblastoma evaluation,
shaken baby syndrome screening and many other paediatric conditions
(Dhaliwal et al., 2009). Although this technique was originally regarded
as relatively simple and easy, challenges such as media opacities re-
sulted in poor image quality. In addition to the Retcam, another system
known as the Panoret-1000 (CMT Medical Technologies, Inc, Valley
Stream, NY), also produces approximately 130° field of view of the
retina by using a contact lens system; however, the Panoret uses scleral
transillumination resulting in less difficulty with lens opacities.
3.5. Optomap
In 2000, the Optomap (Optos PLC, Dunfermline, Fife, Scotland, UK)
noncontact camera was launched for imaging the eye at an angle of
200° field of view, equating to 82.5% of the total retinal surface area.
The Optomap allows detection of retinal pathologies at locations where
otherwise these might be missed if indirect ophthalmoscope or standard
fundus camera image were utilised. The wide-field view was achieved
by employing a scanning laser ophthalmoscope while utilizing an el-
lipsoid mirror to obtain images of the retinal periphery. It uses a red
(633 nm) and green (523 nm) laser to scan the retina and obtain UWFI.
The red and green lasers used to capture an Optomap image produces a
pseudocolour retinal image, which differs from the “true colour” image
produced by a traditional fundus camera using a white-light source.
Apart from obtaining fundus photographs, the Optomap is also capable
of producing high-resolution fluorescein angiogram images of the ret-
inal periphery (vascular structure of the retina) and FAF images. FAF
imaging uses green laser and reveals defects in the retinal pigment
epithelium which contains fluorophores in lipofuscin that emit light in a
range of 540–700 nm range. Advantages of FAF imaging include an
increased depth of the retina captured in a single image, thus over-
coming the anatomical curve of the retina, and the capture of 200°
including the posterior pole and periphery without requiring pupil di-
lation in approximately 0.25 s. Imaging the eye using this device not
only reduces the number of images required to map the fundus, but also
decreases patient exposure to light and patient imaging and waiting
times, which is important in a busy clinic. Although these wide-field
imaging modalities enhanced our understanding of peripheral retinal
diseases and are now valuable research tools, there are still some lim-
itations (Bonnay et al., 2011) (Fig. 7). One limitation is the variability
of the total retinal surface captured between images or imaging ses-
sions. Much of this variability can be attributed to the presence of
image artefacts driven by patient factors such as small pupils, eyelashes,
and eyelids; camera factors relating to illumination and physical set-up;
and intraocular issues such as the brightness of the reflectance superior
of the optic nerve. In addition, presence of small hard drusen-like
“deposits” on the image appearing more frequently in the superior re-
tina in red and green laser separation has been found to contribute to
image analysis conundrums. These artefacts may be due to motion
during image capture, the experience of the photographer, patient co-
operation, and media opacity (e.g. dense cataract). Especially for novice
users the pseudo-colour image may challenge the interpretation of
certain structures (e.g. pigmented choroidal tumours).
Optomap images represent a compromise between area of retina
imaged and resolution required to see relevant retinal changes and so
there is a decreased image resolution(4000×4000) when compared to
other colour fundus imaging modalities (3456× 2304) (Witmer and
Kiss, 2013). The conventional fundus image methods produce a
narrower field of view with good central area resolution whereas the
Optomap will produce a simultaneous view of the posterior pole and
the periphery but with adequate resolution for each. In particular, on
the Optomap image, the temporal and nasal peripheral retina have less
resolution resulting in noticeably fewer details. Distortion and de-
creased resolution mainly occurs around the far temporal and nasal
areas of the periphery. However, there are methods to correct for this
(Spaide, 2011). Peripheral distortion occurs as a result of the Optomap
using an ellipsoid mirror in order to produce wide-field image. The
distortion is particularly apparent in the far temporal and nasal per-
iphery. This means that lesions found in the periphery may look bigger
than they truly are and therefore appropriate corrections must be ap-
plied when measuring peripheral retinal structures (Witmer et al.,
2013).
To address measurement issues, the manufacturer produced a tool
that transform Optomap images into a stereographically projected
image using assumptions based on a model eye with a diameter of
24mm, and thus reducing the impact of peripheral distortion. This was
achieved by ray-tracing every pixel in the Optomap image through a
combined optical model of the Optos 200Tx SLO and the Navarro ultra-
widefield model eye. This combined model represented the “projection”
utilised by the Optos 200Tx platform to create the two-dimensional
Optomap from scans of a respective eye. By reversing this device-
Fig. 7. Artefacts that can appear on Optomap images.
A: the presence of eyelids restricting the view of the retina inferiorly; B: pre-
sence of an eyelid and eyelashes that restricts the view of the inferior retina; C:
camera reflectance on the image and appears a bright green, the image also has
eyelid and camera pad present; D: camera pad present on the temporal retina
restricting the view of the retina. E: pseudocolour Optomap image highlighting
the reflectance that can appear above the optic nerve; F: green separation of
image E: showing the reflectance above the optic nerve, the image also has
eyelid present.
N. Quinn et al. Progress in Retinal and Eye Research xxx (xxxx) xxx–xxx
11
specific projection, a representation of the image data on a three-di-
mensional sphere was created (Croft et al., 2014).
Projection of Optomap images also enables image overlays using the
Registration tool. Registration of images removes any minor shift or
rotation between pairs of images taken of the same eye by auto-
matically adjusting one or more follow-up image to best fit the layout of
the baseline image. Appropriate registration is vital in longitudinal
studies where baseline and follow-up images are captured at different
times. In addition to these tools, the montaging capability serves the
purpose of being able to stitch together images taken using eye-steering
resulting in the widest field of images being generated.
In early 2014, Croft et al. investigated the quantification and
montaging of the retinal surface area on UWFI (Croft et al., 2014). For
accurate quantification of retinal surface and precise montaging of the
steered images, UWFI warping, precision and accuracy were assessed as
a function of different gaze angles. Precision was tested by a standard
retinal surface area being quantified across 10 montages of the same
eye. Once standard areas were measured across the image set, a mean of
408.97mm2 surface area with a standard deviation of 0.7% was found,
this reflected a high degree of precision. No major outlier was found in
any montages, regardless of gaze angles. Accuracy of measurements
was then assessed by quantifying the mean disc area of 50 patients and
comparing them to standard normative disc area measurements with a
range of 1.60–2.63mm2 mean disc areas (El-Dairi et al., 2009). The
authors concluded that precise montaging and accurate quantification
of retinal surface area (mm2) can be achieved in UWFI images (Croft
et al., 2014). In addition, using an intraocular retinal prosthetic implant
of known dimensions as a “ruler” inside the eye, Sagong and colleagues
verified that after stereographic projection (and adjustment for axial
length), retinal measurements could be obtained reliably within 1% of
the ground truth (Sagong et al., 2015).
3.6. Other wide-field imaging technologies
Heidelberg Engineering's (Heidelberg, Germany) Spectralis® equip-
ment produces a 25- and 35- degree retinal field of view with an option
to expand to 55° by using a noncontact lens attachment to attain FAF,
FFA and ICG images. Additionally, the Staurenghi contact lens could be
used with the Spectralis® to provide a 150-degree view of the retina. In
2012, Heidelberg Engineering introduced a non-contact ultra-widefield
angiography (UWFA) module for both the Spectralis® and Heidelberg
Retina Angiograph II models, by using an interchangeable non-contact
lens attached to the camera head (Fig. 8). It captures a single confocal
scanning laser ophthalmoscopy image that is evenly illuminated and
has high contrast across the periphery (Witmer et al., 2013). Fluor-
escein and ICG can be performed individually or simultaneously, re-
vealing clinically relevant peripheral changes such as but not limited to;
non-perfusion, microaneurysms or neovascularisation. In 2014, Espina
et al. presented data from evaluating the non-contact UWFA and ICG
using a modified Heidelberg Spectralis (Espina et al., 2014). They
concluded from examining 35 eyes that a 105-degree retinal field of
view was captured. This device has been utilised for autofluorescence,
infrared, intravenous fluorescein angiography, oral fluorescein angio-
gram and ICG (Espina et al., 2014).
3.6.1. Zeiss CLARUS 500
In late 2017, Zeiss Medical Technology introduced a non-contact,
high-definition UWFI system, the CLARUS 500. The CLARUS utilizes
four LED light sources: Red at 585–640 nm; Green at 500–585 nm; Blue
at 435–500 nm; and an infrared laser diode at 785 nm. The fundus
image produced resembles conventional white-flash photography.
Using the red, green and blue channels true colour images can be se-
parated to help enhance the visual contrast of details in certain layers of
the retina. In addition blue and green autofluorescence allows the vi-
sualization of lipofuscin in the RPE. It also has the capability of pro-
viding an external eye image. In the future Zeiss plans to incorporate
fluorescein and ICG into CLARUS models. In the widefield single image
mode, the CLARUS captures up to 133° of the retina with a 7.3 μm
optical resolution. In the UWFI mode, which involves capturing two
separate images, this device can capture up to 200° of the fundus. A
third, montage mode automatically stitches up to six individual images,
netting up to 267° of the retina in a single display (Appold, 2017). The
manufacturer asserts that ‘true colour’ images produced by the CLARUS
more closely mimic the colouration of the retina seen during dilated
fundoscopy. This may ultimately assist in a more accurate diagnosis and
documentation of retina disorders (e.g. choroidal nevi). However, to
date, no peer-reviewed studies have substantiated advantages of ‘true
colour’ images, nor to corroborate any deficiencies in accurate identi-
fication of retinal pathologies with technologies that blend the red,
green and blue channels (e.g. devices from Optos and Heidelberg).
Moreover, as with the EIDON (see below), direct comparisons among
the available UWFI devices is also lacking.
3.6.2. CenterVue EIDON
The EIDON confocal scanner from CenterVue received FDA clear-
ance in December 2014. This device was the first to combine the con-
focality of scanning laser ophthalmoscope (SLO) systems with ‘true
colour’ fundus imaging. Unlike other SLO devices with monochromatic
lasers, the EIDON utilizes white illumination (440–650 nm) to generate
fundus images whose colouration is more similar to that seen on dilated
fundoscopy. In addition to the colour fundus image, the EIDON is
capable of capturing near infra-red (with an 825–870 nm source) as
well as red-free fundus images. The EIDON's optical resolution is ap-
proximately 15 μm with an image sensor resolution of 14 megapixels. In
Fig. 8. Fluorescein Angiography images taken at 4min (A) and at 5min (B) using the Heidelberg non-contact lens.
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a single image capture, the EIDON camera is capable to capture up to a
60° retinal field of view. Using a programmable internal fixation target,
along with an auto montage software feature, up to 110° of the fundus
may be imaged. This, however, requires four individual fundus photo-
graphs to be taken. Getting closer to the widefield imaging parameters
requires an external fixation and six or more images to be captured, and
even then, only approximately 150° can be montaged into a single
picture. As is the case for the CLARUS 500, peer-reviewed studies
comparing confocal ‘true colour’ images and blended single channel
SLO images are absent, as are comparisons to other widefield imaging
devices.
3.6.3. Wide-field OCT
In 1991, Optical Coherence Tomography (OCT) (Huang et al., 1991)
was first introduced by researchers as a non-invasive, radiation-free
diagnostic technique producing high-resolution in vivo imaging of ret-
inal, choroidal, and optic nerve head structures (Sung et al., 2012).
Following its introduction, OCT has undergone several improvements
such as increased speed, resolution and depth of image. Recently per-
ipheral retinal lesions were imaged with a widefield swept-source OCT
(SSOCT) with a field of view of 4.62±0.62 “optic nerve to fovea dis-
tance units, increasing the single steer field of view (McNabb et al.,
2016). In the same year Choudhry et al. generated far-field OCT images
through eye steering (Choudhry et al., 2016). The field of view of OCT
images are increasing (Shinohara et al., 2018) and it is possible that in
the near future we will be able to capture full-filed OCT without
steering. Overall, it is now possible to image the far periphery with OCT
and this will deepen our understanding of the lesions identified on
UWFI (Choudhry et al., 2016).
4. Comparison of UWFI grading methods
Conventional retinal imaging is well established, and it is im-
perative that new imaging modalities are scrutinized for validity, re-
liability and clinical utility. As early as 2013, the utility of UWFI image-
assisted assessment compared to traditional fundus examination con-
sisting of slit-lamp biomicroscopy and binocular indirect ophthalmo-
scopy was carried out (Brown et al., 2013). Altogether 170 subjects
(339 eyes) were investigated within this study, with image-assisted
examination being superior to examination carried out without ima-
ging. Specifically, image-assisted examination detected 90.6% of drusen
in the posterior pole area compared with 43.8% using no image-assis-
tance. The same was true for the 128 vitreoretinal interface abnorm-
alities detected, where out of the 122 white without pressure 92.2%
was detected using assistance versus 54.7% without. In cases where
both techniques disagreed, a retinal specialist performed an adjudica-
tion using slit-lamp biomicroscopy, binocular indirect ophthalmoscopy,
scleral indentation and a review of UWFI concluded that the image-
assisted examination was correct in 75% of cases. The conclusion of the
study was that non-mydriatic UWFI is useful in detecting and managing
ocular disease in conjunction with traditional examinations though
further work was required to determine the value of UWFI alone
(Brown et al., 2013).
In case of DR clinical studies and research, our understanding of
UWFI is growing steadily as there are now several studies comparing
UWFI to standard imaging. Comparing UWF Optomap images to the
standard Early Treatment Diabetic Retinopathy Study (ETDRS) 7SF,
resulted in a more severe DR grade in many due to the visibility of
additional peripheral lesions in areas beyond the 7SF view (Silva et al.,
2015; Talks et al., 2015; Wessel et al., 2012a). These studies highlight
the importance of UWFI for more accurate diagnosis of severity of DR,
but it requires longitudinal studies to understand the clinical im-
portance of this difference. Standard fundus photography has been an
integral part of ocular examination for well over 40 years, and so un-
derstanding how UWFI compared to such a well-established technique
is paramount. It might be that taking UWFI in one disease will have less
utility than in another, and its adoption for the diagnosis, treatment and
monitoring of retinal diseases will develop on the underlying pa-
thology.
Objective, valid, reliable and reproducible image analysis is the
cornerstone of generating good quality results both for clinical and
research studies. Grading grids existed since the advent of image ana-
lysis using conventional transparencies (film), but these have to be re-
established and re-evaluated for the large area covered by UWFI. Given
the extent of the area available for grading on such UWFI, a grid is
usually used to divide up the area into relevant and manageable sec-
tions so grading of abnormalities can be carried out. Over the years, a
number of grading grids have been developed and in the section below
the advantages and disadvantages for these are to be discussed.
It is instructive to review the development and application of
grading systems for macular disease. The ETDRS grid was first used for
fine-grained documentation of vasculopathy and exudation in 7 over-
lapping 30° fundus photographs viewed stereoscopically (Early
Treatment Diabetic Retinopathy Study Research Group, 1991a; b).
Drusen were assessed, to differentiate them from hard exudates. The
macula was subdivided into 9 zones, one central encompassing the
fovea and foveal avascular zone, and inner (outer diameter at 3mm
radius) and outer rings (outer diameter at 6mm radius) of 4 subfields
each. This grid was used for major epidemiologic studies of AMD in
European-derived populations (Klein et al., 1991, 1992; Mitchell et al.,
1995; Vingerling et al., 1995). Originally designed for inner retinal
pathology in diabetes, this grid captures the distribution of inner retinal
neurons whose metabolic demands dictate the distribution of vessels of
the intrinsic retinal circulation. However, the ETDRS grid has important
limitations for mechanistic insight on outer retinal disease including
AMD. It does capture the division of macula into cone-dominant and rod-
dominant sub-regions (central subfield vs inner and outer subfield).
However, the grid combines the cone-only foveola and mixed rod-cone
parafovea in the central subfield, and it omits altogether a horizontally
oriented elliptical ring of high rod density that localizes to the edge of
the grid and extends nasally around the optic nerve head.
4.1. Moorfields grid
In 2008, the Moorfields grid was developed and was initially de-
rived from the International Classification for AMD system of dividing
the macular area into 3 central zones. The Moorfields grid is loaded
onto an individual Optomap image once the user set the location of the
optic disc and fovea manually and then allowed the system to set up the
grid on the image, centred on the macula. The standard Wisconsin age-
related maculopathy grading scheme (WARMGS) grid was modified
with additional two grading zones added based on the distance between
the centres of the optic nerve head and the foveola (defined to be
4500 μm). Zone 4 represents the mid periphery, which has a diameter of
11000 μm, and zone 5 consists of the far periphery representing all
areas outside of zone 4. The Moorfields grid can only be loaded on
unprojected Optomap images, without correcting peripheral distortion.
Once the concentric rings were fitted, the zones were subdivided into
four quadrants through the centre of the fovea, resulting in superior and
inferior nasal quadrants and superior and inferior temporal quadrants
(Lengyel et al., 2015). See Fig. 9A.
4.2. Manchester Grid
The Manchester Grid (MG) was initially developed for grading
ischemia in fluorescein angiograms for Professor Paulo Stanga at the
University of Manchester (Sala-Puigdollers et al., 2013). The grid in-
itially utilised three ellipses that divided the retina into three different
zones: posterior pole, mid-periphery and periphery, to facilitate grading
of DR. This was replaced with x- and y-coordinates centred on the fovea
(0, 0). The MG covers the retina with approximately 754 squares with
each square being approximately one optic disc area in size (1.77mm2)
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(Jayadev et al., 2016). See Fig. 9B. Each grid rectangle can be labelled
with the numbers 1 to 5 with mouse clicks, depending on the pathology
being graded. Once an image is graded and saved a spreadsheet is au-
tomatically generated displaying the co-ordinates of the pathology and
its approximate size. The MG therefore maintains fine spatial location
information about a lesion as well as quantitative information, in an
unbiased manner.
4.3. Opera Grid
The Opera Grid was developed for grading AMD within a sub study
of Age-related Eye Disease Study (AREDS) 2 called Optos Peripheral
Retina AMD (OPERA) study (Domalpally et al., 2017; Friberg et al.,
2014). The images can be graded on both un-projected and projected
Optomap images. It displays the Studies of Ocular Complications of
AIDS (SOCA) grid which is placed on the image based on the user
providing the fovea and disc locations (AIDS Clinical Trials Group,
1992). The SOCA grid is divided into three zones: Zone 1, Zone 2 and
Zone 3. Zone 1 was 6000 μm diameter area centred on the fovea and
approximately the area enclosed by the vascular arcades, Zone 2 ex-
tending anteriorly from zone 2 to the anterior borders of the vortex vein
ampullas (the furthest anterior that could be photographed easily) and
Zone 3 extends from Zone 2 to the ora serrata. Zone 1 and Zone 2 are
both divided into four quadrants, superonasal, superotemporal, in-
ferotemporal and inferonasal. Zone 3 is divided into two hemispheres
(superior, inferior) using a visual extension of the horizontal cross line.
A properly aligned grid has the centre point of Zone 1 at the centre of
the line that connects the disc to the macula. The outer circle dividing
Zone 2 and 3 crosses the vortex veins. See Fig. 9C.
The OPERA grid was based on a grid developed for trials of ganci-
clovir treatment of cytomegalovirus retinitis (AIDS Clinical Trials
Group, 1992; Holland et al., 1989) in order to assess progression of
virus infection and permanent vision loss and the utility of antiviral
treatment in clinical trials. Zone 1, the macula, was the portion of
where this infection would have been immediately sight-threatening.
This grid may be less useful for assessing diseases involving neurode-
generation, because the macula was not subdivided into fovea and
perifovea, and the peripheral zones did not take into account radial
asymmetries in distribution of retinal neurons, which were described
and quantified after the grid was initially developed (Curcio and Allen,
1990; Curcio et al., 1990).
4.4. Boston grid
More recently Oellers et al. developed a novel grid to study per-
ipheral retinal abnormalities of AMD on projected images (Oellers
et al., 2017). This proposed grid is based on image size rather than
dimensions of the human eye and consists of three concentric zones
with crosshairs centred on the fovea. The first zone (radius of 29mm)
corresponds with the ETDRS grid. The second zone is the perimacular
area (radius of 65mm). This zone was defined based on clinical ob-
servations and, interestingly, corresponds to observations made in an-
other UWFI study that defined this area as the arcade zone (Lengyel
et al., 2015). The last zone separates the mid and far periphery and it is
located on the vortex veins (radius of 160mm). See Fig. 9D.
4.5. Comparison of different grids
Different grids subdivide the back of the eye in different ways. The
Opera grid is centred half way between the fovea and the optic disc
(Fig. 9C), whereas the Moorfields (Fig. 9A), Manchester (Fig. 9B) and
Boston (Fig. 9D) grids are centred on the fovea, allowing comparison
with standard fundus images of the past (Csutak et al., 2010). For de-
tail, the |Manchester grid exceeds all others as it contains 754 zones
(Sala-Puigdollers et al., 2013), which are useful especially in long-
itudinal studies (Quinn et al., 2017). However, grading takes sig-
nificantly longer than that of the other three grids. The OPERA grid has
10 zones, the Moorfields grids has 12, and the Boston grid has 16; these
allow faster, though less detailed grading.
To compare the information generated by using the different grids,
we selected 114 UWF images that had been graded for hard drusen
using the Manchester grid, then we interpolated a hard drusen grading
with the other 3 grids (Fig. 10). Based on this, clinicians and researchers
can draw their own conclusion about which one is better for a given
application. As the images were selected from a general population,
comparison of the outcome can only be made in relationship to the
Moorfields grid that was designed for the population-based Reykjavik
Eye Study (Lengyel et al., 2015). Similar to the finding of the Reykjavik
Eye study, there is a higher prevalence of far peripheral hard drusen
phenotype in this sample of the general population (Lengyel et al.,
2015) as well. The detailed Manchester grid can define locations within
the general zones of the other grids; whether this has clinical relevance
will need further investigation. It might be also important to point out
that none of the grids currently takes into account the distribution of
neuronal cells in the retina (see section 2).
5. Peripheral retinal lesions
The evaluation of retinal periphery plays an ever-increasing role in
screening, diagnosing, monitoring and treating retinal diseases. Indeed,
several studies have suggested that wide-field imaging can be a useful
adjunct to the standard clinical exam, improving the diagnosis of dia-
betic retinopathy and the extent of retinal detachments as two examples
(Brown et al., 2013; Kornberg et al., 2016; Manjunath et al., 2015).
These advantages of widefield imaging may be particularly apparent to
the general clinical user in patients with poor pupillary dilation or
media opacity where standard ophthalmoscopy may be challenging.
One of the most striking findings from several studies are that virtually
all eyes have what would be classified as an abnormality present within
the peripheral region (Denniston and Murray, 2009). Covering all le-
sions in detail is beyond the scope of this paper, but we have produced a
comprehensive list of lesions with relevant references in Table 2. Some
common lesions are to be discussed in Section 7 below.
Fig. 9. Currently available grading grids.
Moorfield's grid (A), Manchester Grid (B), Opera Grid (C), Boston grid (D).
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6. New insight into retinal disease from wide-field imaging
As wide-field imaging is increasingly integrated into standard
practice, it has been noted that the presentation of disease in the pos-
terior pole does not always mirror the severity of that seen in the retinal
periphery and vice versa. Using UWFI new insights have been gained
into a number of common retinal conditions:
6.1. Retinal vein occlusion (RVO)
RVO is a common retinal vascular disease; causing vision loss in
many of those affected. RVO occurs more frequently in patients with
ischaemic heart disease, hypertension and diabetes mellitus. Depending
on the location of the occlusion it can be classified as either central
(CRVO) or branch retinal vein occlusion (BRVO). RVO is characterised
by retinal vascular tortuosity, retinal haemorrhages, cotton wool spots,
optic disc swelling and macular oedema. In a CRVO retinal haemor-
rhages will be seen in all retinal quadrants whereas in a BRVO retinal
haemorrhages will be seen in the area where the vein is occluded
(Karia, 2010). Prasad et al. investigated whether peripheral angio-
graphic features of BRVO and hemicentral retinal vein occlusion
(HRVO) are associated with macular oedema and neovascularisation
using UWFA imaging and concluded that areas of untreated retinal
nonperfusion may encourage the production of biochemical mediators
which in turn trigger macular oedema and neovascularisation (Prasad
et al., 2010). Singer et al. (2014) examined the extent of peripheral
retinal nonperfusion in RVO on the effect of macular oedema severity
using UWFA and OCT and reported that people with a higher ischaemic
index correlated with greater macular thickness and worse vision in
RVO. Following treatment, OCT imaging showed that the more is-
chemic an eye was the greater the decrease in retinal thickness, and this
was accompanied by improved visual acuity.
6.2. Age-related macular degeneration
AMD is the leading cause of irreversible central vision loss among
the elderly population. To elucidate the prevalence and significance of
AMD-like lesions in the periphery, several studies used UWFI in patients
with AMD. In 2013, Tan et al. found that peripheral FAF abnormalities
using UWFI (Optos 200Tx, Optos, Dunfermline, Scotland) occurred in
68.9% of patients with AMD. There were several distinct patterns of
peripheral FAF, including granular (46.2%), mottled (34.0%) and
nummular (18.1%). Significant risk factors for FAF abnormalities were
AMD type (neovascular or non-neovascular), older age and female sex.
Some colour photography features had a high correlation with specific
FAF patterns: these included granular FAF with peripheral drusen and
mottled FAF with RPE depigmentation (Tan et al., 2013). Another study
investigated peripheral FAF in patients with AMD and found that wide-
field FAF imaging revealed a significantly increased central and per-
ipheral FAF signal as well as an increased peripheral FAF irregularity in
patients with AMD with or without anti vascular endothelial growth
factor (anti-VEGF) treatment compared with eyes in the control group
(Reznicek et al., 2012). In 2015, Lengyel et al. investigated the re-
levance of peripheral retinal AMD-like within a population based co-
hort. Presence or absence of hard, crystalline, and soft drusen; retinal
pigment epithelial changes; choroidal neovascularisation (CNV);
atrophy; and hypoautofluorescence and hyperautofluorescence were
graded in the peripheral retina. In 18.9% of eyes examined there was no
pathology detected in the macula or periphery; however in 57.4% of
eyes, AMD-like pathology was detected in both the macula and per-
ipheral retina. In 13.6% of eyes, AMD like changes were found in the
macula alone and in 10.1% of eyes, AMD like lesions were found in the
peripheral retina only (Lengyel et al., 2015). More recently, Guduru
et al. examined subjective grading of UWFA images in AMD patients
and if there was an association between peripheral FAF abnormalities
and AMD. They found that there was a moderate agreement in the in-
terpretation of peripheral FAF abnormalities. FAF abnormalities ap-
peared both in AMD patients and controls; however people with AMD
were at a greater risk of FAF abnormalities (Guduru et al., 2017).
These studies provided interesting insights into the potential asso-
ciations between macular and peripheral changes (See section 2.6). It is
clear that further work is needed to determine if the development and
progression of retinal pathology related to AMD in the peripheral retina
is associated with the development and progression of changes found in
the macula. This should provide both mechanistic insights into the
pathophysiology of the condition as well as practical insights into
whether imaging and assessing the peripheral retina should be a
priority for clinicians treating AMD patients.
Fig. 10. Spatial distribution of hard drusen using the Moorfields, Opera grid,
Boston and Manchester grid respectively.
Moorfield's grid: centre ring (black) represents zone 3 (ETDRS equivalent),
middle ring represents zone 4 (mid-periphery) and outer represents zone 5 (far-
periphery). Opera grid: centre ring represents zone 1, middle ring represents
zone 2 and outer represents zone 3.
Boston grid: centre ring (black) represents zone 1 (ETDRS equivalent), the
second ring represents zone 2 (perimacular area), the third ring represents zone
3(mid-periphery) and outer ring represents zone 5 (far-periphery). The location
of the foveola labelled with “x” and the optic disc labelled with “o”. Red: high
prevalence of hard drusen; White: absence of hard drusen; ST-superotemporal;
SN-superonasal; IN-inferonasal; IT-inferotemporal.
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Table 2
Shows a description of retinal features and diseases and if UWF imaging was used on these retinal lesions and diseases.
Lesion/Disease Description Has it been investigated using
UWF retinal imaging?
Chorioretinal Atrophy A condition where both the choroid and retina are damaged. It can be classified as: diffuse or patchy. It is
characterised by choroidal depigmentation and thinning of the retina. (Tokoro and SpringerLink, 1998)
Y (Salcedo-Villanueva et al.,
2015)
Retinal detachment It is characterised by the separation of the neurosensory retina (NSR) from the RPE. This causes a build-up
of subretinal fluid between the NSR and RPE. The key types of detachment are; rhegmatogenous,
tractional, exudative and combined tractional-rhegmatogenous (Bowling, 2015f)
Y (Bonnay et al., 2011;
Bowling, 2015f)
Congenital Hypertrophy of the Retinal
Pigment Epithelium (CHRPE)
CHRPE is a benign lesion that appears on the retina as a round usually well-defined lesion that typically is
dark grey in colour. It may contain lacunae and a ‘halo’ like lining of hypopigmentation surrounding it.
CHRPE can be classified into three entities (solitary, grouped or multiple pigmented fundus lesions) each
with their own distinct features and implications (Youhnovska et al., 2013).
Y (Shneor et al., 2014; Turgut,
2015)
Bear Tracks Known as grouped (multifocal) CHRPE. They appear a lot smaller than regular CHRPE and without the
lacunae and ‘haloes’. They appear in groups with a pattern resembling animal footprints hence the name
‘Bear Tracks’ (Bowling, 2015c).
Y (Ly et al., 2015)
Peripheral Drusen It is characterised by the gathering of small/yellow deposits on the retina made up of waste products from
degenerating RPE cells, lipids and some proteins. It is appears similar to the drusen found at the posterior
pole only differing location (Rudolf et al., 2008a).
Y (Aslam et al., 2014)
Choroidal Melanoma It appears as an irregular or oblong feature that has abrupt elevated edges. It can be pigmented or non-
pigmented with overlying subretinal fluid and orange pigment (Bowling, 2015a).
Y (Bowling, 2015a; Kernt
et al., 2010)
Vitreous Haemorrhage This occurs due to the disruption of healthy or diseased retinal vessels that causes extravasation and/or
leakage of blood into the vitreous of the eye. It may also be due to the growth of abnormal retinal vessels
(Manuchehri and Kirkby, 2003). It may be diffusely spread throughout the vitreous cavity, or the blood
may conform to the anatomy of the vitreous. For example, haemorrhage in the subhyaloid space may
result in a scaphoid (boat-shaped) haemorrhage.
Y (Kim et al., 2014)
Asteroid Hyalosis (AH) AH is a degenerative condition that affects the vitreous humour of the eye. It consists of spherical bodies in
the vitreous cavity most commonly found inferiorly. (Kador and Wyman, 2008)
Y (Ogino et al., 2014)
Retinoschisis This is a vitreo-retinal dystrophy characterised by the splitting of the sensory retina into two layers; inner
and outer layer. It is most likely due to vitreous traction where the retina is pulled apart. It may appear
either shallow or bullous and retinal vessels appear dark due to light being blocked (Selaru et al., 2000).
Y (Agarwal et al., 2015)
Sclerosed/Ghost Vessels Vessels become sclerotic when retinal vessels pass through an area of degenerating retina. It is known as
sheathing of the vessels. When the anterior surface becomes involved, the entire vessel appears opaque.
When sheathing encircles the wall it produces a wire like vessel.
N
Snail Tracks This is a vitreoretinal degeneration that is similar to lattice degeneration. It appears like shiny ‘snowflakes’
on the retina. It is usually well-defined and oblong in configuration (Bowling, 2015e).
Y (Kothari et al., 2012)
Pavingstone Pavingstone degeneration is characterised by patches of chorioretinal atrophy that coalesce into groups.
Pigmentation may surround the lesion. It is more commonly found in the inferior retina (Bowling, 2015c).
Y (Kothari et al., 2012)
Lattice This is where there is a break of the internal limiting membrane with atrophy of the neurosensory retina
apparent. It appears spindle shaped and often sclerosed vessels form. It is commonly bilateral found both
superiorly and inferiorly (Bowling, 2015e).
Y (Kothari et al., 2012)
Peripheral Cystoid degeneration This is characterised by the appearance of small vesicles with indistinct boundaries on a white/greyish
background. It is thought to be present in all adult eyes, increasing in extent with age (Bowling, 2015c).
N
Diabetic Retinopathy It is a microvascular disease that is characterised by the damage of small blood vessels due to high glucose
levels. It is characterised by micoaneursym/macroaneursym, exudates, cotton wool spots, intraretinal
microvascular abnormality, dot and blot haemorrhages and venous loops or beading (Bowling, 2015b).
Y (Liegl et al., 2014; Silva
et al., 2014)
Gyrate Atrophy (GA) GA is a chorioretinal dystrophy that is relatively rare. It is characterised by well-defined patches of
chorioretinal atrophy in the peripheral retina. GA affects myopes and as people age these lesions tend to
increase in size and number and coalesce throughout the retina (Kaiser-Kupfer Mi, 2002).
Y (Paciuc-Beja et al., 2014)
Choroideremia (CHM) Choroideremia is an X-linked degeneration characterised by atrophy of photoreceptors, RPE and choroid.
Areas of RPE atrophy are seen initially in the periphery and progress centrally.
Y (Morgan et al., 2014)
Retinitis pigmentosa (RP) RP isn't a single disease but a group of hereditary disorders. It is characterised by the degeneration of both
the RPE and photoreceptors. (Natarajan, 2011). On the fundus RPE degeneration can be seen throughout
the retina, pale optic disc and thinner retinal vessels (Jones et al., 2016).
Y (Jones et al., 2016; Ogura
et al., 2014)
Retinal Dialysis This is an expression used when describing retinal holes that appear at the ora serrata. In around 5% of
cases dialysis is bilateral most commonly found in the lower temporal area. Demarcation lines and cysts
are also associated with retinal dialysis (Tasman, 1974).
N
Choroidal Rupture Choroidal ruptures occur due to ocular trauma. It is characterised by a break in the choroid, Bruch's
membrane and RPE. It may appear as a yellow or white sub-retinal streak, which may be linear or curved
in shape. (Ament et al., 2006)
N
Metastasises of the Choroid It appears as a yellow/orange subretinal mass, colour depending on where the primary tumour is. It is
associated with the accumulation of subretinal fluid and its location again depends of the primary site
(Arepalli et al., 2015).
Y (Coffee et al., 2009)
Retinoblastoma This is a rare form of childhood cancer occurring in approximately 1:18000 live births. It is characterised
by the cells of the retina growing rapidly and out of control (Bowling, 2015d). It classically presents with
one or multiple nodular, white or cream coloured masses often associated with increased vascularisation.
N
Sickle Cell Retinopathy (SCR) SCR can be classified as either proliferative or non-proliferative. In the non-proliferative stage the most
common clinical finding is salmon patched haemorrhages in the peripheral retina. In the non-proliferative
stage the most common clinical finding is retinal neovascularisation in the peripheral retina following
vaso-occlusion (Melo, 2014; Mudvari et al., 2010).
Y (Cho et al., 2011)
Cytomegalovirus retinitis It may appear asymptomatic, however if symptoms do arise they include floaters, vision problems and
blind spots. It appears irregular in configuration and is characterised by retinal whitening which appears
granular, haemorrhages may also be present (Heiden et al., 2007).
Y (Mudvari et al., 2010)
Giant Retinal Tear (GRT) GRT is a full-thickness neurosensory retinal break measuring > 90° that extends circumferentially around
the retina for three or more clock hours in the presence of a posteriorly detached vitreous (Shunmugam
et al., 2014).
Y (Meyer and Saxena, 2010)
(continued on next page)
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Table 2 (continued)
Lesion/Disease Description Has it been investigated using
UWF retinal imaging?
Stargardt disease/Fundus
Flavimaculatus
It is characterised by the presence of white to yellow dots that surround pigmentary maculopathy and can
extend to the midperiphery (Armstrong et al., 1998).
Y (Zein and Brooks, 2012)
Familial Exudative Vitreoretinopathy
(FEVR)
This is a rare disorder that can be inherited. It affects retinal angiogenesis thus the vascularisation of the
peripheral retina remains incomplete and poor vascular differentiation is visible (Gilmour, 2015). In
serious cases pre-retinal neovascularisation and fibrosis at the junction between vascular and avascular
retina can occur that causes traction of the macula and retinal vessels.
Y (Trese et al., 2012)
Susac syndrome (SS) This consists of a triad of symptoms; encephalopathy, branch retinal artery occlusion (BRAO) and hearing
loss. It is a very rare disease and can be misdiagnosed due to this (Nazari et al., 2014).
Y (Kumar et al., 2013)
Marfan syndrome This is a connective tissue disorder affecting the skeleton, eyes and cardiovascular system in particular. In
relation to the eyes the signs and symptoms are myopia, early glaucoma and/or cataracts and detached
retina (Dean, 2002).
Y (Rahmani et al., 2013)
Retinitis Punctata Albescens This is a disorder of the sensory retina and retinal pigment epithelium. It is thought to be congenital and
characterised by white dot like lesions that are found scattered deep to the retinal vessels (Smith et al.,
1959).
N
Chorioretinal coloboma It is often associated with other changes in the eye, these include microphthalmos, high myopia,
glaucoma, cataract, and phthisis bulbi. A major risk of coloboma of the choroid is retinal detachment
(Jesberg and Schepens, 1961).
Y (Barnard et al., 2012)
Retinal Haemorrhage They can be RNFL haemorrhages arising from pre-capillary arterioles. They can also be intraretinal
haemorrhages that occur at the venous end of the artery that result in a dot/blot appearance. Deeper
darker round haemorrhages occur due to retinal infarcts that happen in the middle retinal layers
(Bowling, 2015b).
Y (Nakagawa and Skrinska,
2001)
Retinal Hole This is full thickness degeneration of the sensory retina. It appears round to oval in shape and may have a
white collar representing localized detachment.
Y (Kothari et al., 2012)
Floaters They appear as hairlike, dark grey or black in colour due to the shadow they form by blocking exiting laser
light. They take a variation of sizes and appearances on the retina and hide underlying retinal detail.
Floaters are thought to be due to an age-related process or due to ocular trauma, asteroid hyalosis, foreign
bodies or retinal tears (Sebag et al., 2014).
N
Horseshoe Tear This is due to vitreous traction of the retina. A tear is pulled from the sensory retina in the shape of a
horseshoe. They are most commonly seen between the ora serrata and equator where the retina is thinner.
N
Choroidal Naevus This is a benign lesion that is characterised by the accumulation of melanocytes. They are usually
asymptomatic and appear black to slate grey in colour and can have pigmentary changes present. It has
well defined edges and can be flat or slightly risen. Over time drusen may be present on the lesion. A nevus
is closely followed as it may evolve into a malignant melanoma (Gordon-Shaag et al., 2014).
Y (Gordon-Shaag et al., 2014)
White without Pressure (WWOP) WWOP is a retinal phenomenon that is described as an area of retinal whitening which blocks the view of
the underlying choroid. It is thought to be due to vitreous traction. WWOP occurs in the far periphery and
never takes the same configuration between eyes (Orlin et al., 2013).
Y (Orlin et al., 2013)
Exudates Exudates appear as waxy yellow lesions that take a ring-like configuration with relatively distinct margins.
They are caused by chronic localized retinal oedema (Bowling, 2015b).
N
Cotton Wool Spots They appear as small fluffy whitish lesions that block the view of underlying blood vessels. They are made
up of debris from the nerve fibre layer (Bowling, 2015b).
N
Cholesterol Embolus They are small, yellow reflective lesions. Usually there are multiple present on the retina. They are seen at
arteriolar bifurcations and can move or even disappear (Rousseau et al., 2013).
N
Acute posterior multifocal placoid
pigment epitheliopathy (APMPPE)
APMPPE is a posterior uveitis. Clinically, it appears as grey-white lesions on the retina. There is usually
multiple present and appears in both eyes. At the site of APMPPE there is usually pigment clumping
(Mrejen et al., 2013).
Y (Mrejen et al., 2013)
Vogt-Koyanagi-Harada (VKH) In most cases VKH is a bilateral disease affecting multiple organs of the body. In the eye it is characterised
by panuveitis with iridocyclitis, serous retinal detachment, diffuse choroidal swelling and optic disc
hyperaemia (Agrawal and Biswas, 2011).
Y (Heussen et al., 2011)
Birdshot Retinopathy (BSRC) BSRC is an uncommon chronic posterior uveitis. It is characterised by multiple ovoid spots primarily in the
posterior pole/mid-periphery. It usually appears bilateral with a distinctive presentation and a strong
genetic association (Gasch et al., 1999).
Y (Piffer et al., 2014)
Central Serous –Chorioretinopathy
(CSCR)
CSCR is an acquired chorioretinal disorder. It is due to a serous detachment of the retina that appears like
a clear blister. Pigment epithelial detachment and subretinal fluid may also be present (Daruich et al.,
2015).
Y (Nam et al., 2015)
Retinopathy of Prematurity (ROP) ROP is a proliferative disorder that affects the developing vessels of the retina in premature infants. The
main cause of ROP is thought to be the abnormal growth of blood vessels. The growth of these vessels can
lead to retinal detachments and ultimately blindness (Casteels et al., 2012).
Y (Fung et al., 2014;
Theodoropoulou et al., 2013)
Microaneurysms This appears as a tiny area of blood protruding from the retinal capillary wall. They form either by focal
dilation or by fusion of two arms of a capillary loop (Bowling, 2015b).
Y (Leicht et al., 2014)
Coats' Disease Coat's disease is characterised by a defect in retinal vascular development which ultimately leads to leaky
vessels, subretinal exudation and detachment of the retina. It is thought to be more frequent in men and
appears unilateral (Black et al., 1999).
Y (Bass et al., 2011)
Pathological Myopia Myopia is characterised by the extreme increase in axial length of the eye and the formation of posterior
staphyloma(s). Lesions also may appear in the posterior pole including, myopic choroidal
neovascularisation, myopic tractional maculopathy, myopic optic neuropathy and myopic chorioretinal
atrophy (Kaneko et al., 2014).
Y (Kaneko et al., 2014)
Acute zonal occult outer retinopathy
(AZOOR)
It is an idiopathic syndrome which involves loss of function in one or more zones of the outer retina. It is
characterised by photopsias and/or scotoma. Some cases present with a grey/white ring surrounding the
involved part of the retina i.e. acute annular outer retinopathy (AAOR). Chronic stages have signs of
atrophy of the RPE and/or intraretinal pigment migration.
Y (Shifera et al., 2017)
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6.3. Retinopathy of prematurity
Retinopathy of Prematurity (ROP) affects the vasculature of pre-
maturely born babies’ eyes. This disease is biphasic: first causing de-
layed retinal vascular growth, followed by hypoxia-induced patholo-
gical vessel growth (Chen and Smith, 2007). It may be mild with no
visual defects, however it may also be aggressive with the formation of
new vessels, possibly progressing to a retinal detachment. The Optomap
has become increasingly popular with studies reporting its capability of
capturing clinically useful images documenting retinal features known
to define ROP (Patel et al., 2013), using the “flying baby” technique to
facilitate image acquisition. Historically, Retcam has been the standard
imaging modality for monitoring ROP. However, the comparison of
Retcam and Optomap for their ability to capture high quality ROP
images in ROP showed that Retcam takes significantly longer to capture
an image and is particularly difficult to use in older babies due to the
excessive head movements. They reported reduced distress response
and found that Optomap could potentially help monitor ROP progres-
sion and document regression following treatment more reliably (Patel
et al., 2013). Dai et al. evaluated the efficacy of wide field retinal
imaging utilizing the Retcam 2 wide field digital camera for screening
of ROP and found a sensitivity and specificity of 100% and 97.9% re-
spectively when compared to the gold standard binocular indirect
ophthalmoscopy in detection of treatment requiring cases. Their con-
clusion supported that wide field imaging of ROP infants is accurate,
reliable and efficient in detecting treatment requirements. This could
potentially improve cost, detection rate and accessibility of ROP care
(Dai et al., 2011).
6.4. Retinitis pigmentosa
Retinitis pigmentosa refers to a diverse family of inherited eye
disorders characterised by degeneration and dysfunction of rod and
cone photoreceptors. Rod photoreceptors are more commonly affected
than cones; thus retinitis pigmentosa often affects the peripheral retina
first due to the high density of rod photoreceptors present there com-
pared to cones (Hamel, 2006). Most subtypes of retinitis pigmentosa are
characterised by pigment deposits (bone spicule pigmentation) initially
in the peripheral retina (Hamel, 2006). There is limited data in the
literature regarding the use of UWFI in retinitis pigmentosa. In 2013
Kaufman et al. used the Optomap UWFI and UWFA to report the pre-
sence of vascular leakage in the peripheral retina of 15 of 25 patients,
suggesting not only vascular dysfunction but also an inflammatory
component may play a role in the pathogenesis of this disease (Kaufman
et al., 2013). In 2016 a study used UWFA on a patient with retinitis
pigmentosa and intermediate uveitis. They picked up peripheral pre-
retinal exudates, clinical features of retinitis pigmentosa, disc leakage
and cystoid macular oedema identifying both pathologies in a single
investigation using UWFI (Tripathy et al., 2016). This further stresses
the advantages of using UWFI techniques for its ability to simulta-
neously capture pathology in the central and peripheral retina.
6.5. Uveitis
Patients with uveitis can be challenging to image and manage and
accurate diagnosis of peripheral affection can be vital for diagnosis and
management. In the peripheral retina uveitis is characterised by vas-
cular leakage, non-perfusion and neovascularisation to name a few
(Hamel, 2006). The use of UWFA allowed for more complete evaluation
of patients with uveitis showing more excessive disease activity than
apparent from fundus examination, leading to more aggressive and
potentially more efficacious treatment (Kitchens et al., 2009). Campbell
et al. investigated whether the use of UWFI influenced the management
of disease in patients with non-infectious posterior uveitis. Management
of disease in clinical judgement alone as well as both clinical judgement
and FAF traditional fundus imaging led to an alteration of management
for a total of 17 patients out of 43. However, with the addition of UWFI
analysis, treatment was modified in those 17 patients as well as an extra
14 patients out of the 43. This led to a 33% increase in treatment
modification even in such a small study sample. The study concluded
the use of UWFI can aid in management of non-infectious posterior
uveitis; however, further studies are required to determine if these
findings would improve patient outcomes (Campbell et al., 2012).
6.6. Pathological myopia
Myopia is of significant global public health concern due to its in-
creasing prevalence and earlier age-of-onset (Leo and Young, 2011). In
western populations, the prevalence of myopia is low in children
compared to the significantly higher prevalence rates in Asian popu-
lations where a prevalence of 6% in 6 year olds rising to a staggering
70% by the age of 15 has been reported (Kaneko et al., 2014; Leo and
Young, 2011). Pathological myopia causes several characteristic
changes including an increased axial length of the eye and peripheral
retinal thinning. Retinal lesions associated with pathological myopia
include: myopic choroidal neovascularisation (Avila et al., 1984),
myopic maculopathy, myopic optic neuropathy and myopic chorior-
etinal atrophy; these have all been detected already using traditional
imaging techniques (Kaneko et al., 2014). A relatively small study of
highly myopic eyes examined the retinal vasculature using UWFI and
found numerous abnormalities of the retinal vasculature in the far
periphery such as retinal capillary telangiectasia and retinal capillary
microaneurysms. None of the eyes analysed developed retinal neo-
vascularisation. Further research is required to examine if peripheral
changes occur before posterior changes as this could lead to quicker
diagnosis, prognosis and treatment of pathological myopia (Kaneko
et al., 2014).
6.7. Cytomegalovirus retinitis
Cytomegalovirus (CMV) retinitis is a retinal inflammation that can
ultimately lead to blindness. It is primarily seen in patients whose im-
mune system is compromised. Lesions associated with CMV may appear
in the central and peripheral retina, these include: white granular zones
of retinal necrosis, associated haemorrhages and low-grade iritis and
vitritis (Heinemann, 1992). A relatively small study compared Optomap
imaging with standard fundus imaging in CMV retinitis patients and
found that 48.3% more retinal area and 40% more retinitis were cap-
tured and found with UWFI. In two cases the standard fundus photo-
graphy missed peripheral CMV lesions, this could have had disastrous
consequences for the eye and the patient and so they concluded that
Optomap imaging CMV patients is of benefit (Mudvari et al., 2010).
6.8. Ocular markers of disease in the peripheral retina
Due to the ease of examination and the possibilities in imaging the
eye, it is sometimes referred to as the “window to the soul”(Foster and
Khaw, 2009). The ability to non-invasively image both the retinal
vasculature and neural layers provides the opportunity to develop early
markers of systemic diseases. Such markers have been extensively
studied for systemic diseases such as cardiovascular disease and dia-
betes, while OCT imaging led to interest in markers of neurological
diseases such as multiple sclerosis and Alzheimer's disease (AD). As
UWFI technology developed, markers in the retinal periphery are also
being sought and comparisons between presentation in the macular and
periphery undertaken. For some conditions, the initial assumption that
evaluation in the macula is sufficient is gradually being undermined as
data accumulate from wide-field imaging from a variety of systemic
disorders.
6.8.1. Diabetes mellitus
It is understood that the worldwide prevalence of diabetes mellitus
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(DM) was approximately 366 million in 2011, predicted to rise to 552
million people by 2030 (Whiting et al., 2011). DM is one of the leading
systemic diseases affecting people's vision. A variety of ocular diseases
is associated directly with DM; DR, Diabetic Macular Oedema (DMO),
cataracts, anterior ischemic optic neuropathy (AION), diabetic pa-
pillopathy and ocular movement disorders (Jeganathan et al., 2008). Of
these, DR is the most commonly diagnosed ocular complication and is
the leading cause of legal blindness in working age adults around the
world, but not in parts of the UK anymore (Liew et al., 2014). Pre-
viously, the bulk of DR research concentrated on retinal vascular
changes such as microaneurysms, vascular abnormality and increased
vascular permeability, however more recently degenerative changes are
being recognised as well (Barber, 2003). Our detailed and systematic
understanding of features of DR started in 1968, when the Airlie House
Symposium evaluated knowledge and understanding of DR. The main
outcome of this meeting was a standardized DR classification (Goldberg
and Jampol, 1987). Over the years, DR classification underwent
changes, such as in 2003, when Wilkinson et al. produced a more
simplified classification system (Wilkinson et al., 2003): 1) No apparent
retinopathy; 2) Mild non-proliferative DR; 3) Moderate non-pro-
liferative DR; 4) Severe non-proliferative DR; 5) Proliferative DR.
Recently several research studies concentrated on UWFA and its
reliability in DR evaluation compared to traditional techniques. UWFA
produces a wider view and has been shown to have better reproduci-
bility than standard FA methods for classifying DR (Friberg et al.,
2008). Wessel et al. compared UWFA (Optomap Panoramic 200A) and
conventional 7SF angiography and found that Optomap captured more
non-perfusion, neovascularisation and panretinal photocoagulation
than 7SF imaging (Wessel et al., 2012b). These findings were largely
replicated by UPMC Eye Centre, Pittsburgh, showing that retinal
ischemia was better detected using Optomap (Friberg et al., 2008),
confirming that Optomap captured and revealed significantly more
pathology in the diabetic eye than the conventional 7SF imaging.
In 2015, three studies evaluated the effect different imaging mod-
alities have on detecting DR related retinal abnormalities. Talks et al.
(2015) examined identifications of retinal new vessels comparing the
use of the Optomap, the UK's DR screening two field imaging and 7SF
photography and showed that 30% more new vessels were detected on
Optomap than on 7SF imaging (Talks et al., 2015). Price et al. found
substantial agreement (0.8) between the severity of DR based on Op-
tomap and 7SF but noted that a minority of patients were diagnosed
with more severe DR using Optomap. (Price et al., 2015). Manjunath
et al. compared OCT and Optomap imaging to clinical examination of
DR on a large sample of 2040 eyes and showed that UWFI was more
sensitive when compared to clinical examination. They recommended
that using both UWFI and OCT deciding on DR severity would lead to
enhanced quality of assessment (Manjunath et al., 2015).
Kong et al. carried out a pilot study for evaluating DR by the use of
UWFA. UWFI were obtained from 59 patients with diabetes (118 eyes);
11 eyes with no DR, 71 eyes with non-proliferative DR (NPDR) and 36
with proliferative DR (PDR). Findings showed that on UWFI micro-
aneurysms were seen in more than half (54.5%) of those patients with
no apparent DR on conventional imaging; with this percentage pro-
gressively increasing with NPDR (84.2%) and PDR (100%) patients. In
NPDR and PDR patients new vessels in the periphery and ischemia were
detected using the Optomap FA (Kong et al., 2012). This group con-
cluded UWFA had significant advantages in detecting and evaluating
peripheral retinal lesions due to its wider field of view and this was
found to be especially advantageous in cases where detectable pa-
thology was seen on the periphery before any pathology was seen on
the posterior pole.
The relationship between peripheral retinal ischemia and the pre-
sence of diabetic macular oedema (DMO) is a topic currently being
investigated by several studies. Wessel found that on UWFA, out of the
122 treatment-naïve eyes of 70 subjects with DMO, 66 eyes (62%)
displayed areas of retinal peripheral ischemia, (p < 0.001). These
findings suggested that UWFI may provide useful information in as-
sessing peripheral retinal changes associated with DMO (Wessel et al.,
2012b). In analysis of subjects in the Efficacy and Safety Trial of In-
travitreal Injections Combined with Panretinal Photocoagulation for
Clinically Significant Macular Oedema Secondary to Diabetes Mellitus
(DAVE) clinical trial, Fan and colleagues observed that the severity of
ischemia in eyes with DMO appeared to increase with increasing dis-
tance from the fovea (Fan et al., 2017). Non-perfusion in the mid-per-
iphery, but not in other regions, was associated with severity of DMO.
A target pattern scan laser (Pascal) retinal photocoagulation (TRP)
was designed to treat areas of retinal capillary non-perfusion and in-
termediate retinal ischemia regions in PDR. UWFI was used to detect
areas of peripheral retinal ischemia and neovascularisation in order to
guide TRP laser to the four quadrants of the retina. The researchers
found that UWFI-guided laser treatment was a promising procedure for
treatment of PDR as it destroyed less normal retinal tissue than tradi-
tional methods yet obtained favourable disease regression rates at 3–6
months (Muqit et al., 2013).
In 2013 Silva et al. assessed DR lesions identified by UWFI and
compared these to ETDRS 7SF. The lesions identified included hae-
morrhages and/or microaneurysms, venous beading, intraretinal mi-
crovascular abnormality and new vessels elsewhere. UWFI demon-
strated substantial agreement with ETDRS film photographs in
determining DR severity. Additional lesions identified by UWFI sug-
gested a more severe assessment of DR in 10% of eyes than suggested by
lesions found within the ETDRS view (Silva et al., 2013). However, the
implications of peripheral lesions on DR are unknown and further
studies will need to be carried out to evaluate this. More recently, Silva
et al. (2015) reported that the presence and increasing extent of per-
ipheral lesions were associated with increased risk of DR progression
over 4 years, suggesting that detailed peripheral retinal evaluation
provides important information necessary to assess risk of DR pro-
gression (Silva et al., 2015). Currently, there are studies ongoing to test
the clinical significance of peripheral DR lesions in relation to the de-
velopment, diagnosis, progression and choice of DR treatment mod-
alities. Once these studies report their results, a re-classification of DR
might be required in order to incorporate the peripheral lesion in the
clinical pathway.
Most studies exploring visual loss in DR focused on visual acuity;
however, numerous studies using perimetry showed DR's detrimental
effects on peripheral visual function and field (Duh et al., 2017;
Nentwich and Ulbig, 2015; Shrestha and Kaiti, 2014). Importantly,
these studies noted that using perimetry for tracking peripheral visual
function captures early diabetes related pathologies better than tradi-
tional fundoscopy or visual acuity testing (Greite et al., 1981; Guy,
2012; Henricsson and Heijl, 1994; Jackson and Gardner, 2014).
A perimetry study dating back to the 1980s illustrated deficits in
peripheral visual functioning before central visual changes could be
noted in DR patients. Such visual impairments include visual dysfunc-
tion in dim light and difficulty in recognizing contour of objects in low
contrast conditions even when visual acuity is unaffected (Hyvarinen
et al., 1983). However, most research emphasizes central acuity loss
over peripheral visual field monitoring due to DMO related visual loss'
immediate impact on social functioning. (Duh et al., 2017; Lee et al.,
2015). Early perimetry studies illustrated that these peripheral field
deficits and smaller isopter areas could be observed even in DR patients
where neovascularisation, haemorrhage, or microaneurysm weren't
observed (Wisznia et al., 1971).
Recent studies utilizing automated perimetry support these early
findings; additional studies have also shown a decreased ability in
diabetics with DR to recognize objects with low spatial frequency in the
periphery, similar to studies performed on AD and AMD referenced in
this review. These effects were seen in patients with type 2 diabetes
who were diagnosed for ten years or less and before any vasculopathies
could be visualized in the peripheral retina by imaging (Bell et al.,
2010). In agreement, a study from 2008 found that an automated
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Humphrey Perimetry program found reduced peripheral visual func-
tioning in those with type 1 diabetes before vascular changes were
noted in both peripheral and central retina. It should be noted though
that this study only studied as far out to 30 degrees of visual functioning
(Parravano et al., 2008).
A 2013 study on patients with type 1 diabetes illustrated that per-
ipheral visual dysfunction could be seen in the early stages of DR before
images could capture vascular changes. Disease onset was so early in
patients with diabetes that deficits in perimetric testing of the periph-
eral visual fields weren't significant; however, those with diabetes
showed poorer performance and significantly higher variability in total
performance. Even without visualization of peripheral retinal patholo-
gies, perimetry is still highly sensitive at detecting the onset and pro-
gression of DR (Isabel Pinilla et al., 2013).
Recently, perimetric studies sought to correlate these peripheral
visual deficits with the onset of retinal pathologies. Some claimed that
deficits noted on perimetric monitoring of vision might predict future
vasculopathies, but lately it seems that visual peripheral deficits are
associated with areas of lowered autofluorescence, outside the macula
of course (which is protected by an accumulation of luteal pigments).
One 2011 study was able to correlate visual deficits, as tracked by
Humphrey perimetry, with areas of lowered FAF in DR patients.
Although the AF images were taken by traditional fundoscopy (at 40°),
they were visualized outside the macula. The study showed that while
no vasculopathies or lesions could be visualized in these areas, the vi-
sual dysfunction corresponded to areas of lowered AF, presuming these
areas were vulnerable to ischemia or retinal cell dysfunction (Midena
and Vujosevic, 2011).
Many of these studies suggest that the visual deficits perceived in
the setting of early DR are due to vascular insufficiency and that these
can be imaged early if the correct imaging methods are used. However,
if we were better able to screen for onset and subsequently determine
the progression of DR, it might aid us in treating the disease early and
maintaining visual function for longer in patients with diabetes.
6.8.2. Alzheimer's disease and cognitive decline
50 million people living with dementia worldwide and this number
will be 152 by 2050 (Alzheimer's Disease International, 2018). AD is the
most common type of senile dementia in aging adults amounting to
10% of people aged 65 or over being affected. AD affects 24.3 million
individuals worldwide, with around 4.6 million new cases reported
each year (Reitz and Mayeux, 2014). AD clinically manifests by pro-
gressive loss of memory, changes in behaviour, mood and thinking
processes (McKhann et al., 1984). Diagnosing AD is based on clinical
presentation and therefore is difficult in any given patient. Definite
diagnosis can only be made pathologically by examination of the brain
tissue at autopsy (Braak and Braak, 1997). In the early stages of disease
assessments relies on psychological assessments and costly and highly
invasive clinical tests (Neugroschl and Wang, 2011). Therefore, there is
a need to find biomarkers that is objective, could be used repeatedly,
could be used for early detection and monitoring progression and a
procedure that patients are comfortable with and can comply with it
easily even at a more advanced stage of disease.
The retina is part of the central nervous system; it shares embry-
ological origin and anatomical characteristics with the brain (Byerly
and Blackshaw, 2009; Risau, 1997). As such, it has been proposed that
changes in the retina may reflect changes in the brain and provide
accessible biomarkers for AD (Colligris et al., 2018; Dehghani et al.,
2018; Frost, 2010; Ikram et al., 2012; Liao et al., 2018; Lim et al.,
2016). In general, imaging of the retina is non-invasive, well tolerated
and readily repeatable in follow up studies. Using OCT/OCTA in AD,
several studies report thinning of RNFL, macular volume loss and al-
tered retinal vasculature, implying that similar changes take place in
the retina than in the brain (Coppola et al., 2015; Cunha et al., 2016;
den Haan et al., 2018; den Haan et al., 2017; Doustar et al., 2017;
O'Bryhim et al., 2018; Wang et al., 2018). Quantitative and qualitative
changes in retinal microvasculature using conventional fundus photo-
graphs showed an association between cognitive decline/AD and retinal
vascular characteristics (McGrory et al., 2017). Further studies sug-
gested that there is increased arterial reaction time in people with AD
(Mroczkowska et al., 2015) and there is an overall increase in vessel
calibres when peripapillary B-scans are evaluated (Csincsik et al.,
2016). However, all these measurements were carried out on the pos-
terior pole of the eye without consideration for the peripheral retina.
Based on observations on flat mounted retinas of cadaveric eyes
(Lengyel et al., 2004; Ukalovic et al., 2018) it was proposed that
monitoring the development and progression of pathology in the per-
ipheral regions might serve as a valuable tool in detecting and mon-
itoring the progression in age-related diseases such as AMD and AD. It
has been shown that UWFI is comparable to normal fundus imaging
(Csutak et al., 2010) and can detect pathological abnormalities at the
peripheral retina (Csincsik et al., 2018; Lengyel et al., 2015). Recent
pilot study revealed an association between AD and peripheral hard
drusen formation and changes to the vasculature beyond the posterior
pole using UWFI (Csincsik et al., 2018). Similar results were found in an
independent study that showed patient with moderate AD has higher
burden of peripheral retinal deposits compared to aged matched con-
trols or mild cognitive impairment (MCI) (Whitson et al., 2016). Retinal
amyloid deposits also been detected in mid-peripheral region of the
retina using modified ophthalmoscope after oral administration of
curcumin (Koronyo et al., 2017). Based on these findings, it is feasible
to speculate that imaging not only the central but the peripheral retina
too has potentials to be used as biomarkers for progression of disease.
To test the validity of retinal imaging as biomarkers several ongoing
dementia studies include retinal imaging components. These will ex-
amine drusen deposition, vascular and RPE changes and look for ad-
ditional pathological changes in the eye that may not have been iden-
tified before, especially at the peripheral regions.
Retinal functional changes also have been reported in AD. Studies
have shown that AD patients have difficulty processing and recognizing
environmental scenes, especially those with low spatial frequency or a
lack of details. It is worth noting, however, that visual acuity and colour
recognition in AD is generally comparable to age-matched controls (Lee
et al., 2015; Wood et al., 1997). This suggests a preservation of aspects
associated with central vision in AD. Other studies correlated AD with
an increased incidence of traffic accidents and implicated deficits in
peripheral visual functioning over the degree of cognitive impairment
in the occurrence of these accidents. Motion processing, contrast sen-
sitivity, and depth perception, attributes associated with the peripheral
vision, have also been shown to be poor in AD patients
(Lakshminarayanan et al., 1996; Mendez et al., 1990; Neargarder et al.,
2003; Schlotterer et al., 1984).
The observed effects of AD above focus on a characteristic of vision
itself because these studies are neurological and approach the visual
loss as a result of cortical dysfunction. However, very few studies
sought to localize or quantify a loss in the visual field of AD patients. In
the 1980s (Nissen et al., 1985), there were a few case studies where
Goldmann Perimetry showed dramatic inferior hemifield losses in AD
patients. These results were echoed in a 1995 Humphrey Perimetry
study which again found inferotemporal and inferonasal losses pre-
valent in AD patients (Ceccaldi, 1996; Trick et al., 1995). These studies,
though sparse, both agreed that the peripheral inferior visual field was
greatly upset in the onset and progression of AD (Ceccaldi, 1996; Nissen
et al., 1985; Trick et al., 1995).
A 1996 study tried to correlate these perimetric findings in AD
patients by looking at the visual cortices. By measuring the thickness of
the cuneal and lingual cortex in AD patients, the study hoped to illus-
trate the pathway of visual loss through cortical atrophy. The study
found thinning of the lingual over the cuneal, vice versa, and equal
thinning in its AD patients but did not find a direct relationship or a
direct trend (Armstrong, 1996). The presence of cortical thinning in AD
patients was not as surprising as the fact that this study could not point
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to a definite trend in the visual association cortices despite such similar
attributes observed in peripheral visual functioning in AD. Why AD is
associated with the inferonasal and inferotemporal hemifield losses in
perimetry? Why is AD associated with attributes of peripheral visual
function over central visual function?
Very little new research has been carried out since then in quanti-
fying or localizing peripheral visual loss. In contrast, our understanding
of retinal nerve ganglion health increased (Berisha et al., 2007; Liu
et al., 2015; Marziani et al., 2013). In 2013, frequency-doubling tech-
nology (FDT), a form of perimetry that studies flicker sensitivity (an
attribute of the retinal nerve ganglion cells) found that AD patients had
poor results in their inferior visual fields and concluded that the retinal
nerve ganglion cells of the superior retina must be pathologic or must
endure the greatest insult in AD. These results might suggest the ae-
tiology of the peripheral visual function and observed visual field losses
could directly be due to insult in the retina (Valenti, 2013).
One last attribute to discuss about AD is the presence of halluci-
nations (Chapman et al., 1999). Two different commonly reported
findings in AD that are of interest to the peripheral vision are “illusions”
and “misperceptions.” Illusions involve a patient not being able to
distinguish between two objects in their environment. Another type is
called “misperception,” and this emerges when a subject does not re-
cognize something and makes a best guess as to what it could be. Most
research understands and views these illusions and misperceptions as a
manifestation of damage to the visual cycle occurring in the brain. It is
worth noting that similar delusions are seen in AMD and correlated to
the degree of vision loss in the central retina. This phenomenon is called
Charles Bonnet Syndrome (CBS), and it is understood as a manifestation
of how the brain copes with vision loss, especially in AMD patients
(Berrios and Brook, 1982). CBS also occurs in patients with cataract,
glaucoma, and DR. Some studies suggest that up to 60% of people who
have dramatic sight loss experience it (RNIB, 2016). It could be perhaps
that hallucinations seen with AD have a similar source to those ex-
perienced in patients with other retinal pathologies. These documented
visual disturbances in AD indicate that more understanding into the
relationship between peripheral vision and the progression of AD is
necessary.
7. Future directions & conclusions
In summary, it is evident that the peripheral retina has great im-
portance for the prognosis and overall outcome of systemic diseases
affecting large number of patients. The significance of the appropriate
imaging and analysis of the peripheral retina is being shown in this
review by depicting the various imaging and investigative techniques
clinicians and researcher now have at their disposal. Currently oph-
thalmic imaging is undergoing a major revolution due to the avail-
ability and utilization of technologies from other discipline. Combining
these technological advances with a more complete understanding of
retinal morphology, better molecular understanding of diseases led to
an increased need for examining the peripheral retina in clinical setting.
The need for continued research for the use of UWFI has been high-
lighted by the successes of new studies on diabetic retinopathy. Once
the results of the ongoing studies are fully understood and implemented
in clinical practice, these should result in more complete evaluation,
earlier diagnosis, better prognostication and more appropriate care of
patients. Implementation of UWFI systems into clinical practice will
have to be balanced against with increased costs of such systems,
though as is the case for most technologies, one might anticipate that
costs will come down with time. Consensus on imaging and grading
protocols will be needed for easier comparison of different studies.
Ultimately, clinically relevant methods to test functional changes as-
sociated with UWFI abnormalities will be required; these will need to
fuel wider societal changes leading to better environmental and town
planning taking into account the changes in peripheral vision.
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